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ABSTRACT
The use of insecticide treated materials is a major preventive tool in the global fight 
against malaria and other diseases. Synthetic pyrethroids are the only class of 
insecticides suitable for insecticide heated materials, thus resistance threatens to 
undermine disease control. Detoxification by cytochrome P450-mediated insecticide 
metabolism is a major cause of pyrethroid resistance. However, given the large 
numbers of P450s in insects (>100) there is no easy way of rapidly identifying which 
are involved in insecticide metabolism, which is critical information for vector control. 
This thesis describes the development of novel activity based protein probes (ABPP) 
that are based on a pyrethroid scaffold and can be used to selectively label and identify 
P450s that metabolise pyrethroids.
Activity based protein probes require two functional groups; a ‘warhead' reactive 
functional group that is able to be covalently attached to the active site of the target 
enzyme, and a reporter tag for probe-protein adduct formation for visualization or 
isolation for quantification and identification. Acetylene is a common functional 
group. A wide variety of acetylated molecules were therefore screened against rat 
liver micro somes and individual mosquito recombinant pyrethroid metabolizing 
P450s (CYP6P3 and CYP6M2) to identify suitable mechanism based inhibitor 
molecules. The final probe design and positioning of functional groups was aided by 
in silico analysis of active-site interactions of probes with CYP6P3 models.
Six pyrethroid ABPPs belong to the type II class were synthesized (P3R, P4S, P5R, 
P6S, P7RS and P8RS) with the functional acetylene ‘warhead’ positioned on the 
phenoxybenzyl group in the 2’ or 4’ position, and the acetylene tag positioned either 
at the opposite acidic end of the molecule or in the middle replacing the alpha cyano- 
group. One other probe representing a type I pyrethroid (P2) was synthesized. The 
characterisation of these probes against individual Anopheles gambiae P450s and 
rodent and mosquito microsomes is described.
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Finally, P7RS, which closely resembles deltamethrin, was used to screen and 
selectively pull-down deltamethrin metabolizing P450s from rat liver and whole 
mosquito microsomes. Viable quantities of enzyme for LC-MS/MS identification 
were only obtained from rat pull-downs, reflecting the high P450 content in 
mammalian liver. The majority (84%) of proteins pulled-down were P450s, while the 
rest were phase II drug metabolizing enzymes ie. uridine S'-diphospho- 
glucuronosyltransferase. Flavin containing monooxygenase 3, epoxide hydrolase and 
aldehyde dehydrogenase, suggesting a potential role in deltamethrin clearance in 
vivo. The most abundant protein, CYP2C11 (46% of total protein), was a P450 that 
metabolized deltamethrin, while the next hit (19% of total protein) was an orthlogues 
of a human pyrethroid metabolizing P450, CYP2C19. This striking result 
demonstrates the development of a powerful new diagnostic tool for the direct 
identification of enzymes that are capable of pyrethroid metabolism, and therefore 
associated with metabolic resistance.
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Chapter 1
1. Introduction and Literature Review
1.1. The medical importance of mosquitoes
Insects represent more than half of all known living organisms on earth and inhabit 
nearly all environments. In general, insect vectors are responsible for almost 20% of 
all infectious diseases affecting humanity in developing countries (WHO, 2004), 
with mosquitoes amongst the most common human and animal disease carrier for 
parasites, bacteria or viruses infectious to man (Brandling-Bennett and Penheiro, 
1996; Briseno-Garcia et al, 1996; Gubler and Clark, 1995; Krogstad, 1996; Meslin, 
1997; Roberts et al, 1997a; Sanders et al, 1996; Thompson et al, 1996). Of these, 
malaria is considered to be the most important infectious disease of mankind. It is 
most common in tropical and subtropical regions of the world but it is also 
established in some temperate climates as well (WHO, 2005) (Figure 1.1).
Malaria infection remains a devastating global problem, with an estimated 300-500 
million cases occurring annually. Forty-one percent of the world’s population lives in 
areas where malaria is transmitted. Up to 2.7 million people die of malaria each year, 
75% of them are African children (WHO, 2005), and those that survive severe 
malaria are prone to learning difficulties or may suffer brain damage. Furthermore, 
malaria is a major cause of infant death due to infection of pregnant women, while 
low birth weight and maternal anaemia may occur upon malaria infection of pregnant 
women (Luxemburger et al, 2001; UNICEF, 2004).
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Malaria in humans is caused by infection with one or more of five species of single 
cell Plasmodium parasites (i.e., P. falciparum, P. vivax, P. ovale, P. malariae and P. 
knowlesi) (Cox-Singh etal, 2010; Cox-Singh and Singh, 2008).
The infection is transmitted from person to person by the bite of an infected female 
mosquito of the Anopheles species, such as Anopheles gambiae and An. funestus. The 
female mosquitoes transmit malaria because they need the blood meal as a protein 
source to develop their eggs (Olayemi, 2011).
1.2. Vector control methods
Parasites are becoming increasingly resistant to anti-malarial drugs, which are also 
expensive (Djimde et ah, 2001; Price and Nosten, 2001; Wellems and Plowe, 2001). 
Vaccines are still not available (Plassmeyer et al, 2009). Vector control using 
insecticides thus continues to be the major preventive tool in the global fight against 
vector borne diseases. Indeed selective vector control is an integral part of the 
integrated management of malaria disease for the global strategy adopted by the 
World Health Organization (WHO) (Beier et al, 2008). Selective vector control is 
defined as the application of site-specific targeted use of different and cost-effective 
vector control methods alone or in combination to reduce human-vector contact 
(WHO, 1995). This includes the use of insecticide treated materials. Significant 
advances have been achieved with the development of new formulations to produce 
long-lasting insecticide treated nets (LLINs), which are ready primed with insecticide 
which is wash resistant (up to 20 washes) (Atieli et al, 2010).
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Indoor residual spraying (IRS) is also recommended strongly by WHO, while larval 
breeding site control in some circumstances may be used as a complementary tool to 
the LLINs and IRS as a core intervention method (WHO, 2010).
1.2.1. Insecticide treated nets
Insecticide treated nets (ITNs) are used as a physical barrier against vector mosquitoes 
such as An. gambiae and An. fmestus, which generally bite at night (Nauen, 2007; 
WHO, 1995; WHO, 2010). Successful use of ITNs has occurred in Saudi Arabia, the 
Middle East, India, Thailand, Afghanistan, Malaysia, the Philippine Islands and 
Myanmar in Asia (Das et al^ 1993; Dolan et al, 1993; Jamjoom et al, 1994; Leake 
and Hii, 1994; Rowland et al, 1996; Torres et at, 1997). The WHO has given its 
approval to the use of pyrethroids for the treatment of bed nets. In Africa pyrethroid- 
treated bed nets have shown promise in reducing malaria morbidity and mortality 
(Gatei et al., 2010; Nahlen et al, 2003). Between 2008 and 2010 more than 254 
million ITNs have been delivered to malaria endemic countries in Africa (WHO, 
2010). However, with exposure to only a single class of insecticide there is growing 
concern that the evolution of pyrethroid resistance in mosquitoes will reduce the 
sustainability of ITNs technology for vector control (Hemingway et al, 2006). 
Recently a strong knockdown resistance to permethrin and DDT was found in An. 
gambiae populations from southern Benin, where LLINs and IRS have been planned 
to scale up for malaria prevention in this country (Yadouleton et al, 2010). 
Additionally, metabolism based pyrethroid resistance found in An. funestus collected 
from Tororo, Uganda where the involvement of P450 enzymes has been observed 
(Morgan et al. ,2010).
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1.2.2. Indoor residual spraying
Four different insecticides groups can be used for IRS including the chlorinated 
hydrocarbons (i.e. dichlorodiphenyltrichloroethane (DDT)), pyrethroid, carbamates 
and organophosphates (OPs). With more choice of active ingredient, albeit limited, 
IRS is gaining more attention in vector control interventions for reducing and 
interrupting malaria transmission (WHO, 2006; WHO, 2010) (Figure 1.2). The use of 
IRS has been very successful in malaria control where the number of people protected 
by application of IRS in Africa has increased from 13 million in 2005 to 75 million in 
2009 accounting for 10% of the population at risk (WHO, 2010).
1.3.Pyrethroid insecticides
The chemical characterization of the insecticidal components of pyrethrum flower 
extract {Chrysanthemum cinerariaefolium) has led to the development of the 
pyrethroid family of insecticides. Synthetic pyrethroids are based on the structure of a 
natural pyrethrin. They were developed with the aim of improving the stability of 
natural pyrethrins to light and biodegradation as well as enhancement of insecticidal 
activity. These include allethrin (Yamamoto et al, 1971) the first synthetic pyrethroid 
molecule, and permethrin, deltamethrin and cypermethrin. Of these deltamethrin is 
most widely used as it is one of the most highly potent pyrethroid insecticides (Elliott 
et al., 1973; Katsuda, 1999).
5
Y
ea
rs
__
__
__
__
__
__
__
__
__
__
_
W
H
O
 a
pp
ro
ve
d i
ns
ec
tic
id
es
__
__
__
__
__
__
__
__
__
__
__
__
__
__
IR
S 
IT
N
s
IS
H- iQO c
in si i
rH tH
IS
IS IS
IS IS
un
SI
I
■
£
4^
I
if
fS
a
33
ao
*
-oV 
&
-o
1■*■>eoV
3cren
Oa
3
X
st
a
"s■o3
U
«2ao
."a‘5
•-c
Qi
*3
>
2c.c.
3I
O
SC
©
£
o
.2
52
ri
-
vo
The majority of pyrethroid molecules are esters, with an alcohol and an acid moiety. 
An example is deltamethrin shown in figure 1.3 and figure 1.4. The acid moiety 
usually contains a dimethylcyclopropane ring with variable substituent. Most of the 
synthetic pyrethroids contain an aromatic alcohol moiety. All pyrethroids are chiral; 
usually with more than one chiral centre and, therefore, existing as several 
enantiomers. Only a few of the many chiral pyrethroid insecticides are formulated as 
single- or emiched enantiomer products (Ganison, 2006). Pyrethroids such as 
permethiin that lacks an alpha cyano group are classified as type I pyrethroids, while 
those such as deltamethrin that contain an alpha cyano group are classified as type II 
pyrethroids. Pyrethroids display high affinity to Na+- channels where they exert their 
toxic effects by keeping the Na+-channels open, causing complete depolarisation of 
the nervous membrane (Figure 1.3) (Narahashi, 1996; Narahashi et al, 1995).
1.4.Operational problems
The fact that only four insecticide classes are available, and there has been no new 
malaria insecticides approved by WHO in the last 15 years (Figure 1.2), has greatly 
increased concern that insecticide resistance will threaten the sustainability of these 
few chemicals for vector control. Pyrethroid insecticides are particularly vulnerable 
since they are the only group recommended for ITN treatment (Hemingway et al, 
2006; Hougard et al, 2003). This is due to their rapid knock-down effect and low 
toxicity in mammals. Seven pyrethroid compounds are currently considered suitable 
for impregnation of mosquito nets (Figure 1.4) including type I etofenprox, permethrin 
and bifenthrin and type II pyrethroids alpha-cypermethrin, cyfluthrin, deltamethrin and 
lambda-cyhalothrin (Hougard et al, 2003).
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l.S.Pyrethroid resistance
Mosquitoes can develop resistance to pyrethroid insecticides by changing the 
insecticide target i.e. target site resistance, or by overproduction of detoxification 
enzymes i.e. metabolic resistance. Reduced neuronal sensitivity named knock down 
resistance (Kdr) was first recognized for DDT in the 1950’s in housefly (Musca 
domestica L.) (Busvine, 1951). Since DDT attacks the same target as pyrethroids (Na- 
channel) based Kdr resistance has been known for a long time that this can also lead 
to cross resistance for pyrethroids (Fine, 1961). Thus the characterization of Kdr 
resistance to pyrethroid is well documented. For example different Kdr mutations have 
been reported in pyrethroid resistant An. gambiae s.s. from West and East Africa 
(Chandre et al, 2000; Martinez-Torres et al, 1998; Ranson et al., 2000).
A leucine to phenylalanine substitution in the S6 segment of domain II of the para- 
type sodium channel (L1014F) was reported in West Africa (Martinez-Torres et at, 
1998), while leucine to serine in this position (L1014S) is found mainly in malaria 
vectors from East Africa (Ranson et al, 2000). The West Africa Kdr allele (L1014F 
allele) has now been reported in four* other major malaria vectors from South 
Lampung, Indonesia including An. sundaicus. An. aconitus. An. subpictus and An. 
Vagus (Syafruddin et al, 2010).
In addition to Kdr based resistance, metabolic resistance to pyrethroids is possible as 
results of elevated levels of activity of P450s, esterases and glutathione S-transferases 
(GSTs) (Hemingway and Ranson, 2000). Of these, elevated levels of P450 expression 
(transcriptional and/or enzyme activity) are most consistently associated with
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resistance to pyrethroid from African malaria vectors (Brooke et al, 2001; Etang et 
al, 2004; Vulule et al, 1999). For instance the two P450s CYP6M2 and CYP6P3 are 
found over-expressed in permethrin resistant populations of^frz, gambiae in Odumassy 
and Dodowa in southern Ghana (Muller et al., 2008; Muller et al., 2007), Akron and 
Gdedjromede in south-eastern Benin (Djouaka et al, 2008), and Ojoo in south west 
Nigeria (Djouaka et al, 2008). Although little is known about esterase and GST 
mediated pyrethroid metabolic resistance, ester hydrolysis of pyrethroid leading to 
detoxification is believed to act as a cause of metabolic resistance in some instances. 
For example pyrethroid esterase based resistance has been reported in An. gambiae in 
Africa (Vulule et al, 1999). Additionally, the use of fluorescent surrogate substrates 
selectively designed based on pyrethroid scaffold to measure esterase activity proved 
carboxylesterases mediated pyrethroid resistance in Culex pipiens pipiens collected 
from California (McAbee et al, 2004).
1.6.Cytochrome P450 monooxygenase-based resistance
Cytochrome P450s are a complex family of enzymes commonly found in the majority 
of living organisms, including insects. These enzymes are critical for xenobiotics 
degradation and metabolism of endogenous chemicals like hormones, and may have 
played a key role in the adaptation of insects to toxic chemicals in their host plants 
(Feyereisen, 1999). P450s bind molecular oxygen and receive electrons from NADPH 
via NADPH cytochrome P450 oxidoreductase (CPR) to introduce an oxygen molecule 
into the substrate, thus rendering a normally hydrophobic substrate into a more 
hydrophilic and excretable molecule (Figure 1.5). In most cases, oxidative 
metabolism by P450s inactivates insecticides (Kaneko, 2011; Scott, 1999; Scott et al, 
1998), although occasionally the insecticidal activity depends on metabolic activation
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by P450s (Groom et al, 2010; Murray and Butler, 2004; Scott, 1999; Scott et al., 
1998) as in the case of paraoxon. Rapid inactivation will prevent the insecticide 
reaching its target to exert its pharmacological effect. Therefore, P450 mediated 
detoxification leading to insecticide resistance is a major concern (Stevenson et al., 
2011). Cytochrome P450-mediated resistance is probably the most frequent type of 
metabolic based pyrethroid resistance (Scott, 1999).
Due to the large number of P450 genes present in the major malaria vector An. 
gambiae, 111 genes (Nikou D, (2003); Ranson et al., 2002) and large substrate 
diversity it is difficult to identify which P450 is responsible for the metabolism of a 
specific insecticide using available biochemical assays. For instance, An. gambiae 
microarray, the detox-chip, was developed to identify up-regulated detoxification 
genes associated with insecticide resistance (David et at, 2005b). This has identified 
several P450s in An. gambiae associated with pyrethroid resistance, including 
CYP6Z1, CYP6Z2, CYP6M2, CYP6P3 and CYP325A3 (David et al., 2005a; Muller 
et al., 2008; Muller et al., 1994; Muller et al., 2007; Nikou et al., 2003). CYP6Z1 has 
been shown to metabolize DDT (Chiu et al., 2008), CYP6P3 and CYP6M2 metabolize 
permethrin and deltamethrin (Muller et al., 2008; Stevenson et al, 2011), while 
CYP6Z2 binds but does not metabolize pyrethroids (McLaughlin et al., 2008). Among 
those enzymes, the role of CYP6M2 in deltamethrin metabolism that generates 
multiple metabolites in vitro has been characterised using mass spectrometry and 
nuclear magnetic resonance (NMR) spectroscopic analysis (Figure 1.5) (Stevenson et 
al, 2011). Interestingly, 4'-hydroxy deltamethrin (M4) was the major metabolites 
observed in addition to the other metabolites (i.e. Ml, M2 and M3), representing 
complexity of pyrethroid metabolism by P450 pyrethroid metaboliser.
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Figure 1.5. Deltamethrin metabolism by CYP6M2. Boxed compounds were 
experimentally verified. The predominant path for metabolism is indicated by the 
larger arrow and the non-enzymatic degradation of the cyanohydrin intermediate is 
indicated by a dotted arrow (Stevenson et al, 2011).
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The P450 activities are regulated and affected by many factors in vivo, including post 
translational mechanisms (Aguiar et at, 2005), endogenous inhibitors, allosterically 
control and protein-protein interactions (Figure 1.6). Also, alteration of P450 enrymes 
including NADPH-P450 reductases and cytochrome b5 and endogenous 
concentrations of the cofactor NADPH may produce dramatic changes in the P450 
activity (Berge et at, 1998).
Additionally, because eukaryotic P450s are a membrane associated proteins, the 
membrane composition and localization of protein binding partners would be expected 
to have a great influence on P450 activity. Overall these factors may hinder the 
prediction of key P450 isozyme in insecticide metabolism and resistance using the 
current available genomic (microarrays), biochemical assays and proteomic methods.
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1.7.Identification of genes responsible for insecticide resistance
Early detection of the resistance problem may leads to effective resistance 
management strategy in medical, veterinary, and agriculture insect pest. The 
availability of the complete An. gambiae genome sequence has allowed the use of new 
research themes that may leads to development of new effective malaria control tools 
(Hemingway et al, 2002). For instance, quantitative trait loci (QTL), a positional 
cloning approach, has identified a polytene chromosome region encoding two genes 
expressing CYP6P9 and CYP6P4 from pyrethroid resistance strain of malaria vector 
An. fumstus (Wondji et al, 2009). Other available genomic technologies including 
"transcriptional profiling" to study metabolic-based insecticide resistance in malaria 
vectors (David et al, 2005b) and structural analysis (Muller et al, 2008; Stevenson et 
al, 2011) have provided insights into identification of insecticides resistance 
mechanisms.
However, currently available genomics and structural analysis tools are usually 
utilised to indirectly measure the enzymes active in xenobiotics metabolism (hi vitro) 
which in fact can be varied in native proteome environment. Although, biochemical 
assays that measure changes in enzymes activity in proteome’s specimens are 
available (Inceoglu et al, 2009; McAbee et al, 2004; Morou et al, 2010; Shan and 
Hammock, 2001), these measure global levels of enzyme activity, not individual 
isozymes. Therefore, it is essential to find more direct methods to assess the activity 
and functional state of the proteins essential in xenobiotic metabolism and resistance in 
its native proteomic samples. Proteomic methods such as immunobloting assays 
(Western blot) (Morou et al, 2010; Scharf et al, 1998; Zhou et al, 2005) and the
16
methods rely on chromatographic separation including two-dimensional gel 
electrophoresis (2D-GE) and differential gel electrophoresis (DIGE) (Djegbe et al, 
2011; Jin et al, 2010; Jurat-Fuentes and Adang, 2007; Pedra et al, 2005), isotope 
coded affinity tags (ICAT) (Gygi et al, 1999) and multidimensional protein 
identification technology (MudPIT) (Chen et al, 2006; Florens et al, 2002) tandem 
with LC-MS/MS has been introduced for the global analysis of protein identity and 
quantity. However, these methods do not give a direct estimation of enzymes active in 
the whole proteome in which would not be used in monitoring insecticide resistance.
1.8. Activity based protein profiling (ABPP), novel approach for protein activity 
measurements
Activity-based protein profiling (ABPP) is a novel emerging chemical proteomic 
technology that relies on the design of probes to target the active site of a specific 
subset of enzymes by covalent linkage. This provides the basis for a quantitative 
readout of the functional state of individual enzymes in whole proteomes (Patricelli, 
2002). Based on the chemical design of ABPP the selectivity of these probes may be 
tuned to have a low specificity in order to target a wide spectrum of enzymes, or to 
have a narrow specificity to target a few specific proteins (Cravatt et al, 2008). The 
ABPP approach has been applied to profiling protein activities in a wide range of 
diseases including cancer (Jessani et al, 2002), obesity (Bimer-Gruenberger and 
Hermetter, 2007), and parasite invasiveness (Greenbaum et al, 2002a; Greenbaum et 
al, 2002b). It is therefore feasible that this ABPP can be adapted to target the enzymes 
involved with insecticide metabolism in vivo and to examine their functional state in 
relation to resistance.
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1.8.1. General description and design strategies for ABPP
The classic version of ABPP usually utilized probes that contained a warhead (reactive 
group) linker and a reporter tag (typically flurophor or biotin) to profile enzyme 
activities in proteomic samples (Figure 1.7) (Jeffery and Bogyo, 2003; Kidd et al, 
2001; Liu et al, 1999; Saghatelian and Cravatt, 2005). The warhead should be a 
reactive functional group that is able to be covalently attached to the active site of 
specific enzyme, while the reporter tag allows a probe-protein adduct to be visualized 
or isolated for quantification and identification. The chemical architecture of the linker 
ought to connect these two elements, providing selective binding interactions, and 
preventing steric hindrance of the tag onto the probe’s reactive side. For functional 
activity, probe-labelled proteins can be resolved using straightforward one dimensional 
polyacrylamide gel (SDS-PAGE) and visualized by in-gel fluorescence scanning (for 
flurophor based probes) or streptavidin blotting (for biotin probes).
1.8.2. Classification of ABPP
1.8.2.1. Directed vs. non-directed ABPP
Based on the chemical structure of the warhead the ABPP strategy can be classified as 
directed or non-directed. Directed ABPP is designed to target specific classes of 
enzymes, such as serine hydrolases and cysteine proteases (Bogyo et al, 2000; Liu et 
al, 1999; Patricelli et al, 2001), whereas the non-directed approach is used for 
targeting multiple enzymes simultaneously. For example Cravatt and colleagues 
synthesized a library of biotinylated sulfonate esters and applied its members to 
complex proteomes.
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Figure 1.7. Classical ABPP probes design. (A) General components of ABPP probe 
design with examples of electrophile warhead that targeting different enzymes. (B) 
Mechanism based inactivation of fluorophosphonate warhead targeting serine 
hydrolase adapted from (Bogyo et al., 2000). (C) Overview of gel based comparative 
profiling using ABPP probe.The individual sulfonates exhibited unique profiles of 
proteome reactivity where labeled protein was identified as a class I aldehyde 
dehydrogenase (Adam et al, 2001).
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1.8.2.2.Mechanism vs. affinity based ABPP
Based on the nature of covalent linkage of the probe within the active site, the 
mechanism of ABPP can be classified as either mechanism based or affinity based 
ABPP (Figure 1.8) (Jeffery and Bogyo, 2003; Uttamchandani et al, 2008). In 
mechanism based ABPP, the reactive species is generated from the probe by direct 
catalytic activation. For instance, following activation the reactive species can bind 
covalently with catalytic amino acid residue(s) within the enzyme active site, 
producing stoichiometric (1:1) labeling. Mechanism-based probes have been reported 
for many different enzyme classes including serine protease (Bock, 1992a; Bock, 
1992b; Grabarek and Darzynkiewicz, 2002; Kam et al, 1993; Williams et al, 1989), 
cysteine proteases (Nicholson et al, 1995; Thomberry et al, 1994), threonine 
proteases (Bogyo et al, 1997; Wang et al, 2003), metalloprotease (Saghatelian et al, 
2004), tyrosine phosphatises (Kalesh et al, 2010; Kumar et al, 2004; Lo et al, 2002), 
lipases (Deussen et al, 2000; Schmidinger et al, 2005) and PAF-acetylhydrolases 
(Deigner et al, 1999) and glycosidases (Tsai et al, 2002; Vocadlo and Bertozzi, 
2004). In contrast, the affinity-based probes first bind selectively and tightly, following 
which they are induced or activated into forming covalent adducts. Thus endogenous 
target enzyme activity is not required for probe-protein covalent linkage.
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(A)
Inactive enzyme Active enzyme
>Zymogene
> Inhibitor bound
> Post translational 
modification tIrreversible Activity based probe
(B)
Inactive enzyme
>Zymogene 
^Inhibitor bound 
>Post translational 
modification
Affinity-based ABPP design
Warhead Tag
Photo reactive group
Figure 1.8. General description of ABPP strategies classified based on the 
mechanism of covalent adduct with protein target. (A) Activity based -ABPP, (B) 
Affinity-based ABPP (photo reactive probe).
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An elegant example of affinity-based probes are those that contain alkylating 
electrophile or nuclophile that are designed to covalently label amino acid residues in 
their vicinity to the protein active site. Photoreactive probes with photocross-linking 
groups that produce covalent adducts upon light treatment are another example (Figure 
1.8).
1.8.3. Click chemistry-activity based protein profiling probes (CC-ABPP)
I.8.3.I.Copper based CC-ABPP
The major problem with classic version of ABPPs is the presence of the bulky 
"reporter tag", usually a fturophor group (Rhodamine reporter) or biotin group 
(Grreenbaum et al., 2002a; Liu et at, 1999) which can detrimentally effect probe 
function and application (Figure 1.8). The large size of the reporter tags can adversely 
affect probe cell permeability, bioavailability, and protein target interactions. This 
severely limits the usefulness of ABPP, particularly for in vivo monitoring of native 
enzyme activity. The development of click chemistry (CC) has helped to overcome 
this problem.
The click reaction which is now widely applied to biological applications is based on 
the Huisgen-1,3-dipolar cycloaddition of alkynes to azides forming 1,4-disubsituted- 
1,2,3-triazoles (Rostovtsev et al, 2002) (Scheme 1.1). This reaction is catalyzed by 
reduced copper salt ‘Cu (I)’ which is benign (do not degrade proteins) in aqueous 
solution at ambient temperature and doesn’t require protecting groups, or post label 
purification. Furthermore, the triazole is resistant to oxidation or reduction and is not 
susceptible to cleavage, while azide and alkyne functional groups have low reactivity
22
i.e. “are nearly inert” towards biological molecules in aqueous environments. These 
characteristics of the click chemistry reaction inspired Cravatt and co-workers to 
design and synthesise click chemistry-compatible activity based protein profiling 
probes (CC-ABPP) to assess enzyme function in aggressive diseases like cancer 
(Speers et al, 2003; Speers and Cravatt, 2004a; Speers and Cravatt, 2004b).
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(A)
Scheme l.l.Huisgen-13-dipolar cycloaddition of alkynes to azides forming 1,4- 
disubsituted-1,2,3-triazoles known as click reaction (A) Copper catalyzed click 
reaction (B) Proposed copper catalyzed click reaction mechanism (Rostovtsev et al., 
2002).
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This technology integrates click chemistry with ABPP probes to produce tag free- 
ABPP (Figure 1.9), thus overcoming the problems associated with bulky tagged 
probes.
The CC-ABPP can be made by adding a click handle (either alkyne or azide group) to 
replace the reporter "tag": the tag is instead incorporated via CC following probe- 
protein labeling. Speer and Cravat initially reported the conversion of the classic 
ABPP, phenylsulphonate (PS) ester-rhodamine probe to a CC analogue "PS-azide". 
The labeling pattern of the CC-ABPP probe to GSTs was comparable with the 
labeling pattern of the PS-rhodamine (Speers et al, 2003). However-ABPP produced 
much stronger fluorescent signals in protein targets in crude tissue and cell extracts, 
suggesting that elimination of rhodamine tag horn traditional ABPP could accelerate 
the rate of the reaction between probe and GSTs.
The placement of the alkyne or azide on either the ABPPs probe or reporter did, 
however, affect the selectivity, binding kinetics and signal-to-noise (background 
binding) (Speers et al, 2003; Speers and Cravatt, 2004a; Speers and Cravatt, 2004b). 
For example, high background has been reported for PS-azide compared to those run 
with rhodamine-tagged probes. This background problem has been eliminated by 
switching the CC partners of the reporter and tag (i.e., from PS-azide and rhodamine- 
alkyne to PS-alkyne and rhodamine azide) where high levels of activity-based labeling 
was maintained.
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Like the standard ABPP method, CC-ABPP may utilize a fluorophore e.g. a 
rhodamine or biotin group that is linked to a complementary click handle for the 
identification of the probe/protein binding event via a click reaction. Trifunctional tags 
containing the complementary click handle ‘azide group’ as well as rhodamine 
fluorophore and biotin groups have also been used for simultaneous visualization and 
purification of the enzymes of interest, enhancing the utility of these probes (Speers 
and Cravatt, 2004b). For example, Wright and Cravatt successfully used this 
trifunctional reporter for simultaneous visualization and affinity emichment of 
mechanistically labelled P450 enzymes with novel 2-EN-ABP probe (Wright and 
Cravatt, 2007). The 2-EN-ABP was developed by chemical modification of the 
generic mechanism-based P450 inhibitor (Foroozesh et al, 1997; Kent et al, 2001; 
Roberts et al, 1997b) 2-ethynyl naphthalene (2-EN) (Figure 1.10).
The 2-EN-ABP probe has proved to have a relatively broad specificity both in vitro 
and in vivo as shown by labeling of mouse CYP1A2, CYP3A11, CYP2C29, and 
CYP2D9/ CYP2D10, thus allowing alterations in liver P450 activities triggered by 
P450 inhibitors and inducers to be followed (Wright and Cravatt, 2007). Additionally 
the 2-EN-ABP probe has proved capable of labeling a large set of human P450s 
(Wright et al, 2009). More recently a suite of P450-directed CC-ABPPs have been 
produced, which have been designed against a variety of well known chemical 
architectures that are MBIs of the P450 enzyme family (Figure 1.11). Thus there is an 
expanding suite of CC-ABPPs available for the functional profiling of P450, which 
can be used for understanding P450-drug interactions.
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Figure 1.11. Heat maps illustrating probe labeling profiles for individual human 
P450 enzymes. (A) Absolute fluorescence signals of probe labeling events. (B) 
Normalized fluorescence signals of probe labeling events, where data for each P450 
enzyme is shown as a ratio of the strongest labeling signal for that enzyme. A ‘ 1 ’ as 
being the strongest binding event for an individual P450. Negative values in both the 
raw data and normalized data (reflecting less labeling in the presence versus absence 
of NADPH) have been assigned ‘0.’ Fluorescence intensity values are in arbitrary 
units and represent the mean of three independent experiments per P450. (C) Chemical 
structure of CC-ABPP probes directed against CYP enzymes (Wright et ai, 2009).
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I.8.3.2. Copper free CC-ABPP
Although copper catalyzed CC-ABPP has proved its utility to profile the functional 
state of many enzymes in vivo and in vitro, this technology is only applicable for living 
cell imaging when copper cell toxicity is irrelevant. The bio-orthogonal click reaction 
named Staudinger ligation (valiants) which form an amide bond between the azide and 
an ester-derivatized phosphine can be applied for living cell imaging. However, the 
limitations of the Staudinger ligation such as slow reaction kinetics and competing 
oxidation of the phosphine reagents have restricted the wider use of Staudinger 
ligation for dynamic cell imaging. These require faster reaction kinetics and low cell 
toxicity. A strain promoted [3+2] azide-alkyne cycloaddition, a bio-orthogonal Cu-ffee 
variant of click chemistry that can label biomolecules rapidly and selectively in living 
systems has been introduced by Bertozzi and co-workers (Agard et al, 2004) to afford 
faster kinetics and overcome the intrinsic toxicity of the traditional copper catalyzed 
click reaction (Figure 1.12).
This work has opened the way for labeling and visualizing biomolecules in vivo, 
which was difficult to characterize by traditional genetic manipulation. Subsequently, 
a difluorinated cyclooctyne (DIFO) was developed that exhibited greatly (Codelli et 
al, 2008) enhanced reactivity and was effective for bio-orthogonal imaging of azide- 
tagged sugars in living organisms (Baskin et al, 2007).
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1.8.4. Enzyme families addressable by ABPPs
ABPP methods have proved a useful approach for the functional annotation of 
enzymes activities that are myriad and difficult to identify. The application of ABPP 
is increasingly attracting the attention of drug development for drug target for curing 
many diseases. Some of the enzyme families that have been successfully annotated are 
illustrated in Figure 1.13.
1.8.5. Analytical platform for high-throughput, high-resolution ABPP
While SDS PAGE gel is normally utilized for resolving complex proteins labelled 
with ABPP’s probe, quick and direct measurement of gel imaging with a fluorescence 
imager has been exploited using fluorophore labelled proteins (Adam et al, 2002a) for 
comparative profiling of different proteomic samples. Moreover, the liquid 
chromatography-tandem mass spectrometry (LC-MS/MS) based approach has been 
introduced for further identification of proteins targeted by ABPPs. Gel-based analysis 
platforms such as 1D-SDS-PAGE in tandem with LC-MS/MS are routinely used for 
this purpose (Adam et al, 2002c). The limited resolving power and sensitivity of gel 
based methods, coupled with their inability to directly assign molecular identities to 
probe targets, have inspired the advancement of gel-fiee technologies for evaluating 
probe-proteome reactions. The combination of chemical proteomic methods with the 
multidimensional protein identification technology (MudPIT) has been exploited to 
further afford and increase the statistical confidence of protein assignments and get 
insight in quantifying the relative levels of these proteins in comparative proteomic 
experiments (Jessani et al, 2005).
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Cytochrome P450 oxidise alkyne group providing 
reactive species (ketene) that attacks nuclophile 
residue within enzyme active site and form a 
covalent adduct with P450s (Wright and Cravatt, 
2007).
The glycosidase reaction leads to fluoride 
elimination and formation of a highly reactive 
quinone methide that reacts with the protein (Tsai 
etal., 2002).
An acyl phosphate ATP probe prepared from a 
biotin derivative and ATP or ADP , directed activity- 
based protein profiling probes of Kinases (Patricelli 
etal., 2007).
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Figure 1.13. An example of enzymes families addressable by ABPP methods,
chemical structure directed against enzymes classes illustrated where warhead denoted 
red colour.
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The combination between ABPP and MudPIT has been investigated for chemical 
proteomic strategies including ABPP and CC-ABPP (Jessani et al, 2005; Speers and 
Cravatt, 2009). This method is unique for drug target identification as it affords a 
powerful method to enable the discrimination of probes with high selectivity for 
enzyme active sites from those that show unacceptable levels of non-specific labeling. 
The ABPP-MudPIT was first applied to primary human breast tumors to enable the 
identification of enzymes activities of more than 50 probe labelled proteins in a single 
experiment (Jessani et at, 2005).
The CC-ABPP-MudPIT (Figure 1.14) has provided greater sequence coverage 
(Jessani, Niessen et al 2005; Speers and Cravatt 2009) of intact probe labelled 
proteins and circumvents interference from reporter tag compared to traditional ABPP 
and the active site-peptide profiling method developed by Adam et al (Adam et al, 
2004). The high sensitivity and high resolution (owing to affinity enrichment of probe- 
labelled targets and multidimensional separation respectively) are desirable features 
for ABPP-MudPIT further suggesting the suitability of the system to being used in 
dissecting the protein function from any complex proteomic sample.
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Other platforms like capillary electrophoresis (CE) coupled with laser-induced 
fluorescence (LIF) as separation and detection techniques have also been exploited 
towards the goal of developing high throughput ABPP platform (Okerberg et al, 
2005).
To further extend the application and contribution of ABPP technology in comparative 
protein profiling experiments with minimum sample requirement, protein microarrays 
has been exploited. Proteins microarrays provide a novel approach of a miniaturized 
platform of ABPP that can be consolidated into a single step for the isolation, 
detection, and identification of probe labelled enzymes (Figure 1.15).
In comparison with gel-based methods, the outstanding feature of ABPP microarrays 
are that they exhibit much higher sensitivity and resolution. This is illustrated by recent 
analysis of the clinical prostate cancer biomarker, prostate specific antigen (PSA). The 
ABPP microarrays produced a 30 fold increase in sensitivity compared to gel-based 
ABPP and in the range of endogenous serum levels for this serine protease (Sieber et 
al, 2004). However the major limitation of ABPP microarrays is that this approach 
requires prior knowledge of the protein targets of probes and availability of high 
quality antibodies for incorporation into ABPP microarrays.
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Activity-based
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Proteome Probe-labeled
proteome
Antibody microarray
SDS-RAGEmicroarray
concentration (pg/ml)
(C)
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SDS-PAGE
Microarray
Figure 1.15. Analysis of ABPP experiments by antibody microarrays. (A)
Proteomes are treated with flurophor-tagged probes and probe-labelled enzymes 
captured and visualized on glass slides arrayed with anti-enzyme antibodies. Testing 
the sensitivity of ABPP microarrays, (B, C) ABPP microarrays exhibit 30-fold greater 
sensitivity for the detection of PSA activity compared to gel-based ABPP (sensitivity 
limits: 0.002-0.008 and 0.12-0.25 ng/ml, respectively).
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1.9.Research objectives
The main objective of this project is to develop novel pyrethroid ABPP probes for the 
selective labeling and identification of P450s that can metabolize pyrethroids in the 
native mosquito proteome (i.e. microsomes). In the context of malaria control, this will 
allow rapid screening and activity based identification of P450s that are likely to be 
involved in pyrethroid detoxification and resistance.
To achieve this objective, the following approach, described by Chapter, was taken to 
produce pyrethroid ABPP probes:
• Chapter 2. Assuming the alcohol moiety of the pyrethroids deltamethrin and 
bifenthrin to be the primary site of P450 attack, validate the MBI potential of a 
pyrethroid-like alcohol aryl alkyne against rat liver microsomes and the 
pyrethroid metabolizing An. gambiae P450, CYP6P3.
• Chapter 3. Examine the mechanism-based properties of a series of larger 
deltamethrin- and bifenthrin-like arylalkyne analogues for MBI against CYP6P3, 
and join experimental data with computational docking experiments to aid the 
final design of pyrethroid ABPPs.
• Chapter 4, Synthesise pyrethroid ABPPs
• Chapter 5. Validate the pyrethroid ABPPs for their ability to selectively tag, 
detect, enrich, and identify P450s associated with pyrethroid metabolism in the 
native proteome state (microsomes).
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Chapter 2
2. Constructing pyrethroid ABPPs: investigating mechanism-based 
inhibition of P450s by arylalkyne components
2.1.Introduction
The major objective of the thesis is to develop novel pyrethroid ABPP probes capable 
of labelling P450 associated pyrethroid metabolism in an activity based manner. A 
general activity based probe (2EN-ABP) for P450s (i.e. non-specific ABPP capable of 
labelling several P450s) was developed by Wright and Cravatt using a click-chemistry 
approach (Wright and Cravatt, 2007) (see Figure 1.10, Chapter 1). Briefly, 2EN-ABP 
containing a reactive aryl group is metabolised by P450s, producing covalent 
attachment. The enzyme is then labelled with an azide fluorescent reporter by click 
reaction which is detectable by 1D-SDS Gel using fluorescence imager.
A similar approach has been taken here to design a novel set of ABPPs that selectively 
target and profile P450s with activities associated pyrethroid metabolism. Hence a 
pyrethroid structure was envisaged containing aryl alcohol moiety (derivatives of 3- 
phenoxybenzene or biphenyl moiety) which is considered the primary site of oxidation 
by P450s. Thus introducing a reactive alkyne group at alcohol side should result in 
mechanism based inactivation to P450s associated pyrethroid metabolism (Figure 2.1).
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Aryl-conjugated alkynes (aryl acetylene) are known to promote mechanism-based 
enzyme inactivation via a highly reactive ketene intermediate (Figure 1.10, Chapter 1), 
which subsequently acylates nucleophilic residues within the P450 active site, leading 
to enzyme inactivation (Foroozesh et al, 1997; Roberts et ai, 1997b; Wright and 
Cravatt, 2007). A number of criteria are routinely used to assess whether a substrate 
is a mechanism-based inactivator (Silverman, 1995). They are as follows:
1. The loss of enzyme activity must exhibit time dependence (although it is usually 
pseudo first order with respect to time that is not absolutely necessary). Thus, a 
plot of the logarithm of the enzyme activity remaining versus time should give a 
straight line.
2. The inactivation requires that all of the typical cofactors e.g. NADPH are present 
and that metabolism is occurring. The addition of the NADPH should be possible 
to represent metabolism of the inactivator to a reactive intermediate which can 
lead to enzyme inactivation.
3. The inactivation should be irreversible and activity should not return upon 
dialysis or gel filtration since the inhibitor should be covalently bound to the 
apoprotein or the heme prosthetic group.
4. Following inactivation, it should be possible to demonstrate a 1:1 stoichiometry 
of inactivator to enzyme molecule inactivated. In addition, the presence of 
exogenous “scavenger” nucleophiles such as glutathione (GSH) should have no 
effect on the rate of inactivation or the stoichiometry.
5. The inactivation exhibits saturation kinetics with respect to the concentration of 
the inactivator.
However, at least one or two of these criteria should be satisfied for a mechanism- 
based inactivator.
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The MBI mechanism by a terminally acetylated phenoxybenzyl compound has yet to 
be demonstrated. Therefore, as a first step in the rational design of pyrethroid ABPPs, 
the aim of this chapter was to investigate the P450 MBI criteria of l-ethenyl-4- 
phenoxybenzene and other arylalkyne compounds (Figure 2.2A). These compounds 
were chosen for their structural similarity with the alcohol moiety common to 
pyrethroid compounds normally used for vector control (Figure 2.2B).
2.2. Rationale
Because of the difficulties in purifying large quantities of mosquito microsomes, the 
ability of aryl alkynes to act as MBIs of P450s was first investigated using rat liver 
microsomes (RLM), which are enriched with P450s and can be purified in large 
quantity. Inhibition was measured against resofurin activity, for which there is a broad 
spectrum of substrate analogues that are used regularly for monitoring general P450 
activity (Donato et oh, 2004; Foroozesh et ah, 1997). To confirm inhibitor reactivity 
with pyrethroid metabolising P450s, candidates were then screened against known 
pyrethroid metabolising An. gambiae P450s CYP6P3 (Muller et aL, 2008).
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Figure 2.2. Aryl alkynes selected for testing of their MBI potential against CYP 
enzymes. (A) Chemical structure of different aryl compounds bearing terminal 
acetylene 4-ethynyl-l, 2-difluorobenzene (4EDF), 2-ethynyl-6-methoxynaphthalene 
(2EMe), 4-ethynyl-l, T-biphenyl (4EBi), l-ethynyl-4-phenoxybenzene (lEPh) and 
propargyloxyphenyl (2POX). (B) Chemical structure of the Type I and Type II 
pyrethroid templates used for the design of pyrethroid mimetic ABPP.
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23. Results
2.3.1. Dealkylation of 7-alkoxypkenoxazone assay.
In order to determine the best substrate for measuring P450 dealkylation activity in 
RLM, several 7-alkoxyphenoxazone substrates (synonymously known as alkoxy 
resorufin) were screened. Dealkylation of 7-alkoxyphenoxazone is catalysed by P450 
to generate phenoxazone anion. The dealkylation product has fluorescence emission at 
ex 560 mn and em 590nm (which linearly correlates with product concentration). The 
measurement of the phenoxazone anion production vs. time enables catalytic activity 
to be measured in the presence and absence of xenobiotics (e.g. inhibitor). Figure 2.3 
represents typical activity of P450s in microsomes measured for methoxyresorufin-O- 
demethylation (MROD), ethoxyresorufin-O-deethylation (EROD), pentoxyresorufin- 
O-depentylation (PROD) and benzyloxyresorufin-O-depenzylation (BROD).
RLM showed highest activity with MROD and EROD, while only slight activity was 
observed with BROD and none with PROD. Furthermore, kinetic data were estimated 
for MROD and EROD to calculate the linear range of activity and Km value for each 
substrate. Km values were 1.1, 2,3 pM and Fmax was 0.17 and 0.08 pmoles 
resorufin/min/pmoles P450 for MROD and EROD respectively.
Therefore, the residual activity (NADPH dependency) of RLM after incubation with 
inhibitors was measured in the presence of 1 pM methoxy resorufin. Compounds that 
were stronger inhibitors following pre-incubation with NADPH were classified as 
MBIs.
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Figure 2.3 Rat liver microsomes activity with flurogenic substrates. P450 activity 
measured in pmole resorufin/min/pmole P450, error bar refer to standard deviation for 
three replicates (n=3).
45
2.3.2. NADPH dependent inhibition of rat liver microsomes
Preliminary screening of, 2EMe, lEPh, 4EDF, 4EBi and 2POX, was carried out to 
determine the NADPH dependence of inhibition of MROD activity in RLM. The 4EBi 
compound is a known MBI (Foroozesh et al, 1997) and included as a positive control. 
Different concentrations of inhibitor (1.6, 40 and 200 |aM) were incubated in the 
presence and absence of an NADPH generating solution. NADPH dependent 
inhibition was demonstrated by 2EMe, lEPh and 4EBi (Figure 2.4). 4EDF showed 
only minor NADPH dependent inhibition at the higher concentration 200 \iM. 
Therefore, for further investigation of the mechanism based inhibition criteria the 
selected arylalkynes 2EMe, lEPh and 4EDF were taken forward for further 
measurement of kinetic parameters and mode of inhibitor labelling (heme adduct or 
protein labelling).
2.3.3. Inhibition of P450-dependent metkoxyresorufin dcmcthylation activities 
in rat liver microsomes by 2EMe, lEPh and 4EDF
Aryl acetylenes 2EMe, lEPh and 4EDF were investigated for MBI of P450-dependent 
MROD activity in RLM. Figure 2.5.A represents the pseudo-first-order time- 
dependent losses of MROD activity in RLM in the presence of different 
concentrations of 2EMe. The semi log plots of the percent relative activity versus 
different preincubation intervals (0, 5, 10, 20 and 30 min) and concentrations 
demonstrated pseudo-first-order linear time-dependent kinetics for losses of enzymatic 
activity. The decrease of enzyme activity observed rate (ftobs) was calculated from the 
slope of each plot. The Kitz-Wilson plot was obtained by plotting the reciprocals 
values of k0bS vs. reciprocals of the inhibitor concentrations.
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Figure 2.4 MROD remaining activities of P450 in rat liver microsomes after 
preincubation + ■ / -■ NADPH in presence of different aryl acetylene relative to 
control (absence of inhibitor as mentioned in material and methods section).
The Kitz-Wilson plot of the observed inhibition of MROD activity establishes that 
2EMe is a strong suicide inhibitor with a limiting kj„aciivatio>i of 0.016 +/- 0.00057 min.'1 
and Kj of 0.018 pM (Figure 2.5.B and Table 2.1). In a similar fashion, lEPh was found 
to inactivate MROD activity (Figure 2.6.). The tune dependent losses of MROD 
activity shown in Figure 2.6.A indicate that inhibition, especially at higher inhibitor 
concentrations, manifest pseudo-first-order time-dependent behaviour. The resulting 
Kitz-Wilson plot (Figure 2.6.B and Table 2.1), further indicate the suicide inhibition 
with a X/of 2.87 pM and kimctiVation of 0.029 +/- 0.00446 min"1. In contrast, there is no 
time-dependent loss of MROD activity for 4EDF (Figure 2.7).
2.3.4. Cytochrome P450 Destruction Assay
For all inhibitors tested the P450 content in RLM was measured after incubation with 
10 pM of the potential inhibitor in the presence and absence of NADPH. There was no 
apparent reduction in P450 content, suggesting that heme adducts are not formed with 
all inhibitors tested (spectral data shown in Figure A.I.l, A.I.2, A.I.3 and A.I.4, 
Appendix I). Thus for MBIs 2EMe, lEPh and 4EBi, inactivation may likely to occur 
via protein adduct formation.
Mechanism based inhibition parameters from the plots described above for the 
inhibition of MROD activities in RLM by the different ethynyl aryl compounds are 
summarised in (Table 2.1).
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Figure 2.7 Time and concentration-dependent inactivation of rat liver 
microsomes plotted by log of percent relative activity versus time of the MROD 
activity in the absence or in the presence of 4EDF.
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2.3.5. Luciferin based substrate assay for measuring recombinant CYP6P3, 
CYP6M2 and CYP6Z2 activities.
The P450-Glo assays were used to measure the inhibition of recombinant CYP6P3 
after preincubation with selected inhibitors. A comparative activity profiling study was 
carried out to define the optimum substrate for measuring of the P450 activities and to 
give a prediction about the amenability and selectivity of P450 active site for substrate 
recognition. Figure 2.8 represents the results of the comparative profiling of CYP6P3, 
CYP6M2 (both pyrethroid metabolisers) and CYP6Z2 (a pyrethroid non-metaboliser) 
against luciferin based substrates. Out of six luciferin substrates tested four were active 
with the recombinant P450s, although rates of activity were quite variable. In general, 
the larger substrates showed greatest activity. Interestingly, luciferin-PPXE activity 
was only observed with the pyrethroid metabolisers CYP6P3 and CYP6M2, whereas 
no activity was recorded for the non-metaboliser CYP6Z2. This might be a reflection 
of structural similarities between luciferin-PPXE and pyrethroids.
In addition, luciferin-BE activities were observed with all enzymes while no activity 
was observed for luciferin-PFBE. Luciferin PPXE was further titrated against CYP6P3 
to define the linear range of activity (Figure 2.9). Based on this, a concentration of 25 
pM luciferin-PPXE was used to measure NADPH dependent inhibition.
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Figure 2.8 Selectivity of the P450-Glo™ substrates for recombinant An. 
gambiae P450s. Recombinant P450s were assayed for 30 minutes. All CYPs were 
co-expressed with AgCPR. Control reactions used recombinant enzyme without 
NADPH. Luciferin-PPXE activity observed with only pyrethroid metaboliser 
CYP6P3 and CYP6M2. L-BE activities were observed with all enzymes while no 
activity was observed for L-PFBE.
54
16
 p
m
ol
 C
YP
6P
3 
(K
m
 = 
46
 p
M
)
(lAirl) uosiBjjueouoo euuajeoni-a
CD CO O O
(lAiri) uoijejjuaouoo aujja^aon~|-a
a(Ui-
&
>
OhVO
U
O
c
.o
I'4—*
H
<
ro0-
SO
ao•-C
2
c
Vueoo
■Ms
£
#g
*3exos
a>
Co•-C
2
•■c
uH-onJOSGA
©
3
co
nc
en
tra
tio
ns
 o
f L
uc
ife
rin
-P
PX
E 
su
bs
tra
te
. (B
) M
ic
ha
lis
 m
en
tio
n 
ki
ne
tic
s o
f C
Y
P6
P3
 to
 ca
lc
ul
at
e K
m
 o
f L
uc
ife
rin
-P
PX
E.
2.3.6. CYP6P3-NADPH dependent inhibitions
Table 2.2 shows the residual activity of CYP6P3 after preincubation with different aryl 
acetylenes (10 and 100 pM) in the presence and absence of NADPH. To minimize the 
interference from inhibitor concentration in the second reaction with the PPXE 
substrate, the initial (PPXE free) reaction was diluted 10 fold into the second PPXE 
reaction. The selected inhibitors 2EMe, lEPh, and 2POX showed increased NADPH 
dependent inhibition at 100 pM with (3, 11 and 4 fold increases over -NADPH control 
respectively).With 10 pM NADPH the values were 3,1 and 1. In contrast, no NADPH 
dependent inhibition was observed for 4EDF and 4EBi at booth concentration tested.
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Table 2.2 Remaining activity of CYP6P3 after preincubation -/+NADPH with 
chemical compounds
Compounds Chemical
Structure Cone. pM
% Remaining activitya -NADPHb
-NADPH +NADPH +NADPH
2EMe
100 70 22 3
10 147 56 3
lEPh n /“N .
100 64 6 11
K_r°\J— 10 66 69 1
4EDF
F
100 104 114 1
10 109 120 1
4EBi 0^0 ~
100 84 92 1
10 88 101 1
2POX 100 85 21 4
10 102 126 1
No Inhibitor 0 100 100 1
(a) The remaining activity after 30 min preincubation was calculated by dividing P450 
activity in the presence of test compound by the activity in the absence of test compound.
(b) Represents the fold increase in inhibition following preincubation of inhibitor reaction 
with NADPH. Reactions where there has been either no change or an increase in activity are 
scored as 1. 2EMe, lEPh and 2POX, which scores >1, are considered to be MBIs.
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2.4.Discussion
As the first step in the rational design of selective active site-directed “click5 5 
chemistry (CC) ABPP probes for functional analysis of P450s that mediate pyrethroid 
metabolism, lEPh, 4EBi, 2EMe, and 4EDF were investigated for their potential MBI 
against RLM. These small molecules were selected for their structure similarity with 
the alcohol moieties of bifenthrin and deltamethrin structures, representative pyrethroid 
scaffolds for commonly used pyrethroid insecticides recommended by the World 
Health Pesticide Evaluation Scheme (WHOPES) (Hougard et al, 2003). Although, 
planar structures such as 2-EN, 2-POX and 4-EBi were known suicide inhibitors of 
P450s (Foroozesh et al, 1997) there is no literature on lEPh, which is a more flexible 
derivative of the phenoxybenzyl moiety commonly found in pyrethroids. The 
determination of the potential MBI by this type of molecule was thus key to final 
ABPP design.
Here, the MBI by lEPh and other aryl acetylene are described against MROD activity 
in RLM, which was found to be the best substrate for P450 measurements in RLM 
(Figure 2,3). Although PROD activities in rat liver microsomes have been observed to 
be highly selective measures of P450 2B1/2B2 activities in RLM (Foroozesh et al, 
1997) no activity was measured in this microsomes preparation. This might be 
attributed to the lack of CYP2B1/2B2 induction in the RLM used in the current 
investigation.
Preliminary screening of RLM with MROD demonstrated the strongest NADPH 
dependent inhibition by 2EMe, lEPh and 4EBi and weak inhibitions by 4EDF. This 
finding may be attributed to the small size of 4EDF and the higher polarity relative to
58
the other compound tested which might adversely affect enzyme-inhibitor potency. 
Further investigation canied out using 2EMe, lEPh and 4EDF indicates significant 
MBI inhibition for MROD activities in RLM for 2EMe and lEPh (Table 2.1). The 
inhibition parameters calculated for MBI inhibition of 2EMe and lEPh involved both a 
kinetic term (^inactivation and to.s) and a concentration term (Kj). Although, 2EMe showed 
high potency with RLM with a Z/value of 18 nM comparing to lEPh with Kj value 2.8 
|uM, the inactivation rate of lEPh was ~2 fold faster than 2EMe (t0.5 43.3 vs. 23 min 
for 2EMe and lEPh respectively). Since 2EMe contains two terminal functional 
groups (methoxy and acetylene) the notably slow rate of inactivation may be explained 
by the possibility of O-demethylation which might negatively affect the inactivation 
rate. This argument is supported by the fact that the analogous structure 2-EN, which 
lacks a methoxy group, gives rapid inactivation and high potency (Foroozesh et al, 
1997). In addition, the P450 destruction assay indicated that the labelling of P450s may 
be linked to protein adduct formation rather than heme ligation in the active site as 
there is no loss of P450 content in the presence of any of the inhibitors (Appendix I). 
This result is in agreement with previous studies (Foroozesh et al., 1997).
An early study was carried out to test the inhibitory effect of 33 compounds, 
comprising five different structural groups (alkynylpyrenes, alkynylphenanthrenes, 
methylenedioxyarenes, flavones, and miscellaneous), for house fly CYP6D1 (Scott et 
al, 2000). This enzyme has been reported to mediate pyrethroid resistance in the 
Leam-PyR (LPR) strain of house fly (Korytko and Scott, 1998; Liu and Scott, 1996; 
Zhang and Scott, 1996). Interestingly it was found that in general alkynylpyrenes were 
the most potent group of inhibitors, with maximum effectiveness noted when the
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substituent was in the 4 position (the 4'position of the phenoxy moiety in pyrethroids 
is the major site of P450 oxidation).
Since An. gambiae CYP6P3 is a known metaboliser of deltamethrin and permethrin 
(Muller et al., 2008), NADPH dependent inhibition screening was carried out to 
further interpret the MBI of selected potential inhibitors against a P450 pyrethroid 
metaboliser. Because of low activity against resorufm substrates (MROD, EROD, 
PROD and BROD) (data not shown), an alternative P450-Glo assay was used to 
measure the residual activity of recombinant CYP6P3 with inhibitors. The comparative 
profiling screening for six luciferin substrates against CYP6P3 and two other An. 
gambiae P450s, CYP6M2 a pyrethroid metaboliser (Muller et at, 2008; Stevenson et 
al.) and CYP6Z2 a pyrethroid binder but not metaboliser (McLaughlin et al, 2008), 
was therefore carried out. Interestingly both the pyrethroid metaboliers CYP6P3 and 
CYP6M2 demonstrated best activity with the high molecular weight luciferin based 
substmte (L-PPXE). It is possible this may be related to structural similarities of the 
probe with pyrethroids. Therefore the Luciferin-PPXE substrate was taken forward and 
used as probe substrate for determination of CYP6P3 residual activity with selected 
inhibitors.
Although, 4EBi is a known suicide inhibitor of P450 dependent MROD in RLM 
(Foroozesh et al., 1997) and CYP6D1 (Scott et al., 2000), no NADPH dependent 
inhibition was indicated for CYP6P3. However, lEPh and 2POX showed significant 
NADPH dependent inhibition, particularly at the higher concentration of 100 pM 
relative to 10 pM (Table 2.2). This data highlights the fact that both the size and shape
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of the molecule are important parameters for inactivation of CYP6P3. It is possible the 
presence of an ether bond in lEPh and 2POX might play an important role in directing 
the molecule towards heme binding group in CYP6P3 active site. Accordingly, it was 
concluded that lEPh, an analogue of the common phenoxybenzyl moiety in pyrethroid 
insecticides, can act as a MBI as evident by NADPH dependent inhibition of P450 
activity in RLM and the anopheline pyrethroid metaboliser CYP6P3.
The next phase was to assess the ability of lEPh and other molecules bearing terminal 
alkyne groups in larger deltamethrin and bifenthrin analogues to fully assess the 
inhibitory effect in the context of composite pyrethroid molecule. This was examined 
in the next Chapter along with 3D homology modelling of P450 interactions to predict 
the inhibitory mechanisms of these inhibitors.
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2.5.Materials and methods
2.5.1. Chemicals and reagents
Potential inhibitors l-ethynyl-4-phenoxybenzene (lEPh), 4-ethynylbiphenyl (4EBi), 2- 
ethynyl-6-methoxynaphthalene (2EMe), (prop-2-yn-l-yloxy) benzene (2POX) and 4- 
ethynyl-1, 2-difluorobenzene (4EDF), were purchased from Sigma-Aldrich Chemical 
Co. (UK). P450s Flurogenic substrates 7-methoxyphenoxazone, 7- 
ethoxyphenoxazone, 7-pentoxyphenoxazone, and 7-benzyloxyphenoxazone were 
purchased from Sigma-Aldiich Chemical Co. (UK). DMSO and other solvents were 
reagent grade (Sigma Aldrich, UK).
2.5.2. Instrumentation
Cytochrome P450 spectral analysis was carried out using Cary 4000 UV-Vis 
spectrophotometers (VARIAN, UK). Fluorogenic measurement was carried out using 
Fluoroskan® Ascent microplate fluorometer (Thermo Scientific, UK). Luminescent 
measurements (P450 Glo assay) were carried out using LUMI star Omega (BMG 
Laboratories, UK).
2.5.3. Rat liver microsomes preparation
Rat liver microsomes prepared from male Wistar rat which contains 0.52 nmol/mg 
protein was kindly provided by Dr. Alison Shone, Molecular Biochemical Parasitology 
group, Liverpool School of Tropical Medicine (LSTM).
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2.5.4. Preparation ofE. coli membranes expressed CYP6P3
The CYP6P3 membrane and its redox partner cytochrome P450 reductase (CPR) 
expressed in competent Escherichia coli DH5a cells were prepared as detailed by 
Muller et al (Muller et at, 2008), briefly transformant, which was given by Dr. 
Bradley Stevenson, Vector Group, LSTM, was grown in 0.4 1 of Terrific Broth with 
ampicillin and chloramphenicol selection at 37°C until the optical density at 595 nm 
reached 0.8 units. The culture was then cooled to 25°C, supplemented with 0.5 mM 5- 
aminolevulinic acid (Melford, UK) and 1 mM isopropyl p-D-l-thiogalactopyranoside 
(Melford) before incubation continued at 25°C with orbital shaking at 150 rpm. The 
cells were harvested and membranes prepared as described previously (McLaughlin et 
al, 2008). P450 functional expression was quantified by CO-difference spectroscopy 
(Omura and Sato, 1964a) and CPR activity was estimated by cytochrome c reductase 
activity (Pritchard et al, 2006). CYP6P3 was expressed at 50-100 nmol of P450 per 
litre of culture. The isolated bacterial membranes contained 0.428 nmol of CYP6P3 
per mg protein and the specific activity of CPR was 10 nmol reduced cytochrome C 
min 1 mg 1 proteins. Total protein concentration was determined by Bradford assay, 
with bovine serum albumin standards according to standard method (Bradford, 1976). 
CYP6M2 and CYP6Z2 membrane preparation were supplied by Dr. Bradley 
Stevenson, Vector Group, LSTM.
2.5.5. Assay of 7-Alkoxyphenoxazone dealkylation in rat liver microsomes
To define the optimum substrate for measuring the residual activity of P450s after
preincubation with potential inhibitors, the P450 dealkylation activities in RLM were
assayed by different flurogenic substmtes, 7-methoxyresorufin-O-demethylation
(MROD), 7-Ethoxyresorufin-O-deethylation (EROD), 7-resorufin-O-depentylation
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(PROD), and 7-benzoylresomfin-O-depenzylation (BROD) according to published 
method (Foroozesh et al, 1997). Cytochrome P450 enzyme activity was measured as 
function of phenoxazone anion production, the product anion was monitored eveiy 5 
sec by a spectrofluorometer at 560 nm excitation and 590 nm emission. Enzyme 
activity was calculated based on the difference between phenoxazone production vy. 
time in presence and absence of NADPH. The kinetics data were analysed to calculate 
the Km value for substrates and linear range of enzymatic activity by fitting activity vs\ 
substrate concentration to a hyperbolic function using Graph Pad Prism Program 
Version 5.01.
2.5.6. NADPH dependence of inhibitions in rat liver microsomes
The 7-methoxyphenoxazone demethylation assays were run with the following 
modifications; the microsomes were preincubated with the inhibitors in 0.2 M tris-HCl 
buffer containing MgCF for 30 min, in the presence or absence of the NADPH- 
generating solution (1 mM glucose-6-phosphate (Melford), 0.1 mM NADP+ 
(Melford), 1 unit ml 1 glucose-6-phosphate dehydrogenase (G6PDH, Sigma) in a total 
volume of 50 pi).
The 7-alkoxyphenoxazone substrates and required amount of NADPH-generating 
solution were then added, and the production of 7-hydroxyphenoxazone was 
monitored at 590 nm as described above. Control samples were preincubated for 5 min 
in the presence of the NADPH with 1% of pure DMSO instead of the inhibitors.
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2.5.7. Cytochrome P450s residual activity assay estimation
Residual activity of rat liver microsomes after pre-incubation with different 
concentration of potential inhibitors (2EMe, lEPh, 4EBi, 4EDF) was carried out on 
white flat 96 well Microplate. Briefly, in duplicates 50 pi of 0.2 M Tris HC1 buffer, pH
7.4 containing a combination of 2x different concentration of potential inhibitor and
6.4 pmol of RLM were incubated for 3 min at 37° C. Thereafter the reaction was 
initiated by addition of 50 pi of 2x NADPH generating system (1 mM glucose-6- 
phosphate (Melford), 0.1 mM NADP+ (Melford), 1 unit ml-1 glucose-6-phosphate 
dehydrogenase (G6PDH, Sigma) in a total volume of 50 pi) pre-warmed to 37°C to 
yield 0 0.064 0.32 1.6, 8, 40 and 200 pM final concentration of inhibitors. Then the 
microplate was incubated at 37° C for 0, 5, 10, 20 and 30 minutes. After each 
incubation time, the residual activity of P450s were measured by further addition of 
100 pi lx NADPH generating system containing double the Km concentration of 
methoxy-resofurines substrate (7-methoxyphenoxazone). The production of 7- 
hydroxyphenoxazone anion was monitored every 5 sec by a spectrofluorometer at 560 
nm excitation and 590 nm emission. In the absence of inhibitors the product formation 
was linear’ for at least 10 minute. An equation describing product formation with 
respect to reaction time in seconds was obtained for each inhibitor concentration. Data 
analysis was performed by plotting the log of the remaining enzymatic activity percent 
in the presence of inhibitor relative to that in the absence of inhibitor at 0, 5, 10 20 and 
30 min intervals by using Sigma-Plot graphics package (Jandel Scientific, San Rafael, 
CA). For mechanism-based inhibitors, these plots of the change in enzymatic activity 
versus time manifested pseudo-first-order time-dependent losses of activity (Equation 
1).
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At - A0(e kobst^ eq. 1
Where At is the remaining enzyme activity at time t, Aq is the enzyme activity at t=0, 
k0bs is the first-order rate constant for enzyme inactivation determined from the slopes 
of the initial linear decline in activity.
The hyperbolic relationship between k0bS and [7] is fitted by Equation (2) using 
graphpad prism software to derive estimates of Kinactivatjon and K\.
Kkobs ~
(Jtinactivation ^ UY)
« + [/])
eq. 2
Where I, is the initial concentration of the inhibitor, K\ is the apparent dissociation 
constants of the enzyme-inhibitor complexes leading to enzyme inactivation and 
kimctivation. is the rate constant that defines the maximal rate of inactive enzyme 
formation (Silverman, 1995). In addition, the linear regression analysis Kitz-Wilson 
plot (Kitz and Wilson, 1962), a double reciprocal plot of the observed inactivation rate 
constant (&0bs) as a function of mechanism based inactivator concentration ([I]) were 
also used to obtain kimctivation. and Kj values. A plot of l/&0bs against 1/ [I] generates a 
trend line, which has a y-intercept of \lkhiactivation and an x-intercept of-VKj.
2.5.8. Cytochrome P450 destruction assay
Cytochrome P450 destruction assay was carried out according to published method 
(Foroozesh et al, 1997) briefly 1 mg ml'1 of microsomal protein was incubated at 37 
°C for 3 min in 1.88 ml of 0.2 M Tris-HCl buffer, pH 7.4 containing 0.2 mM 
ethylenediaminetetraacetic acid, 3.3 mM KC1, and the appropriate concentration of
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potential inhibitor (in 10 pi of DMSO), and 0.22 ml of the NADPH-generating system 
then was added to start the reaction. A 1.0 ml aliquot was removed immediately (zero 
time) and placed in an iced cuvette. Another 1.0 ml aliquot was removed after 30 
additional min of incubation at 37 °C and was placed in a second ice-cooled cuvette. 
Incubations with 10 pi of DMSO in the absence of the inhibitor were carried out as 
controls. Na2S204 (~1 mg) was added to each cuvette and a reference spectrum from 
400 to 500 nm recorded. CO was gently bubbled into the solution in the cuvette for 1 
min, the cuvette was immediately capped, and the spectrum between 400 and 500 nm 
was measured. The change in absorbance at 450 nm relative to 490 nm, after 
subtraction of the dithionite reduced reference spectra, was used to determine the P450 
content using 91.000 M'1 cm'1 as the extinction coefficient (e).
2.5.9. Luciferm based substrate assay for measuring recombinant CYP6P3, 
CYP6M2 and CYP6Z2 activities.
Luminescent P450 activity assays were performed in all-white 96-well plates (Thermo
Fisher Scientifc, Hudson, NH) using the commercially available P450-Glo (Promega,
Madison, WI) substiutes against CYP6P3, CYP6M2 and CYP6Z2. Luciferein-H,
Luciferin-Me, Luciferin-CEE, Luciferin-Be, Luciferin-PFBE and Luciferin-PPXE
substrates were screened in duplicates at 20 pM substrate final concentration and
0.25pM adjusted P450s concentration in final volume of 50 pi. Double final
concentration of recombinant P450 substrate combination in 25 pi volume were diluted
to 50 pi by addition of 25 pi of an NADPH generating system (1.3 mM NADP+, 3.3
mM glucose-6-phosphate, 0.4 U/ml glucose-6-phosphate dehydrogenase, and 3.3 mM
67
MgCl2 concentrations; BD Biosciences, San Jose, CA) thereafter the plate was 
incubated at 37° C for 30 minutes. The P450 reaction was stopped by the addition of 
50 pi of lucifeiin detection reagent (Promega). After the addition of the Luciferin 
detection reagent, the reactions were incubated at 25° C for an additional 20 min after 
which luminescence was quantified using an integration time of 1 sec and gain of 450. 
The average relative luminescence unit (RLU) values from two wells containing all 
assay components except NADPH were used as a blank. Luminescence readings that 
were not at least two-fold higher than the blank were considered not detectable. A 
standard Luciferin curve (0-2000 nmol/well) was generated and used to convert RLU 
values to nano moles Luciferin produced.
2.5.10. CYP6P3 and luciferln-PPXE substrate titration
Different concentrations (0,0.781,1.56, 3.125, 6.25,12.5,25 and 50 pM) of Luciferin- 
PPXE substrate were titrated with different concentration of CYP6P3 (1, 4 8 and 16 
pmol) to determine the enzyme and substrate concentration combination that give a 
linear range of response. CYP6P3 activity was measured as mentioned above; data 
were fitted by a hyperbolic model using Graphpad prism software to derive the Km of 
PPXE substrate.
2.5.11. CYP6P3-NADPH dependent inhibitions
Recombinant P450 CYP6P3 with CPR, prepared as detailed by Muller et al. (Muller et 
2008), was assayed for residual activity of CYP63 with luciferin-PPXE substrate 
after preincubation with various concentrations (0, 10 and 100 pM) of Inhibitors 
(2EMe, lEPh, 4EDF, 4EBi and 2POX) in a white 96 well plate format at 37 °C. 
Primary reaction was carried out by incubation of 2x inhibitor concentration in a final
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volume of 50 pi contain 20 pmol of recombinant CYP6P3 in the presence of 100 mM 
potassium phosphate buffer, pH 7.6. Reaction was initiated by addition of 50pl 2x 
NADPH generating system after a 3 min preincubation. At 30 min of incubation 5 pi 
aliquots were taken out of the primary incubation mixture and transferred into 45 pi of 
a secondary incubation mixture (10-fold dilution) containing 100 mM potassium 
phosphate buffer, pH 7.6, luciferin PPXE (25 pM/per well) as reporter substrate, and 
NADPH generating system to measure residual activity.
With a 10-fold dilution and saturating concentrations of Luciferin PPXE (25 pM) in 
the secondary incubation, it was assumed that any further inactivation was minimal 
After 30 min of incubation at 37°C the D-Luciferin detected by addition of 50 pi of 
Luciferin detection reagent as P450 Glo assay protocol recommended (Promega, UK) 
and the plate incubated at room temperature for 20 min, then the luminescence signal 
detected by reading the plate at Omega Microplate Readers.
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Chapter 3
3. Rational design of pyrethroid ABPP probes 
3.1.Introduction
Arylalkynes like propargyloxyphenyl (2POX) and 2-ethynyl naphthalene (2-EN) have 
been used for decades as synergists for insecticides such as pyrethroid and carbamates 
(Brown et al, 1996; Fellig et at, 1970; Metcalf et al, 1966; Sacher et al, 1968) 
(Figure 3.1). The phenoxybenzyl moiety of the conventional pyrethroids (e.g. 
cypermethrin) is considered the major site of oxidative metabolism in resistant insects 
(Brown et al, 1996; Scott et al, 2000; Shan et al, 1997).
In an earlier study the phenoxybenzyl moiety was replaced to produce new 
cypermethrin analogues with known P450 monooxygenase blocking groups including 
pentafluorophenyl, methylenedioxyphenyl, and propargyloxyphenyl groups (Shan et 
al, 1997). These compounds were tested for their insecticidal and synergistic activity 
against tobacco budworms that were insecticide-susceptible (LSU) or that expressed 
metabolic resistance to cypermethrin (Pyr-R). Interestingly it was found that both trans 
and cis isomers of a(S), 1 (^)-propargyloxyphenyl-containing compounds were 
insecticidal whereas a(R), 1 (i?)-cz5,-methylenedioxyphenyl- and -propargyloxyphenyl- 
containing compounds were nontoxic but significantly enhanced the toxicity of 
cypermethrin.
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In this project, arylalkynes are being used to replace primary or secondary oxidation 
sites in the alcohol moiety in pyrethroid structures (i.e. deltamethrin and bifenthrin) to 
produce click chemistry activity based protein profiling probes (Pyrethroid ABPP) to 
enable direct functional labelling of P450s associated with pyrethroid metabolism,.
In the previous chapter, the arylalkynes 1 -ethynyl-4-phenoxybenzene (lEPh) and 
propargyloxyphenyl (2POX) were demonstrated to be suicide inhibitors of CYP6P3. 
The aim of this chapter was to understand the structural basis of interactions of 
composite pyrethroid molecules bearing an arylalkyne group using with CYP6P3 to 
aid the design and synthesis of novel pyrethroid ABPP probes.
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Figure 3.1 Summary of mechanism based inhibition of P450s. (A) Chemical 
structure of arylalkyne compounds commonly used as P450 inhibitors (Brown et ai, 
1996; Sacher et al., 1968; Scott et al, 2000) (B) Mechanism based inactivation (MBI) 
illustrating P450-catalyzed oxidation of the aryl alkyne to produce a highly reactive 
ketene that subsequently acylates nucleophilic residues within the P450 active site 
adapted from (Hammons et al, 1989).
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3.2.Results and Discussion
3.2.1. CYP6P3 NADPH dependent inhibitions by bifenthrin and deltamethrin 
analogues
Aryloxypropynes and aryl acetylenes are known to destroy hepatic cytochrome P450 
through a suicidal interaction (MBI) (Fellig et al, 1970; Foroozesh et al., 1997). 
Deltamethrin and bifenthrin analogues containing either propargyloxyphenyl (2POX) 
or 2-methyl substituted analogue of 4-EBi were further examined for MBI against 
CYP6P3 (Table 3.1.). The NADPH dependent inhibition was the criterion for 
irreversible inactivation. In general, deltamethrin and bifenthrin analogues C3 and C4 
bearing the 2POX group displayed NADPH-dependent inhibition at 10 \xM as 
demonstrated by 3 and 2 fold lower levels of activity following preincubation with 
NADPH respectively. In contrast, no inhibition was recorded for Cl and C2 
respectively. Although rigid structures like 4-EBi are proven irreversible inhibitors of 
P450 activity rat liver microsomes (Foroozesh et al., 1997), results in Chapter 2 
suggested this molecule was not a MBI for the mosquito CYP6P3. Nevertheless, 4- 
EBi molecule has been considered here for inclusion in the composite structure of 
pyrethroid analogues for two reasons. First, a part of this molecule (biphenyl moiety) is 
commonly found in commercial pyrethroids such as bifenthrin. Second, it was worth 
testing the effect of the structural rigidity of alcohol moieties containing terminal 
acetylene on the irreversible inhibition of P450 by a pyrethroid structure. Since both 
Cl and C2 are derivatives of the planar 4-EBi, which did not show MBI against 
CYP6P3, this suggest that a flexible aryl ether group such as 2POX or lEPh in a 
pyrethroid structure may alter the molecule configuration to allow for better binding 
and/or metabolism leading to enzyme inactivation.
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Table 3.1.Inhibitory effect of deltamethrin and bifenthrin analogues on CYP6P3
Compounds Chemical Structure Cone.pM
% Remaining activitya -NADPHb
-NADPH +NADPH +NADPH
Cl 10 78 95 1
C2 10 88 65 1
C3 10 50 15 3
C4 10 21 13 2
Deltamethrin
o cw
10 110 96 1
No inhibitor 0 100 100 1
(a) The remaining activity after 30 min preincubation was calculated by dividing P450 activity 
in the presence of test compound by the activity in the absence of test compound, (b) 
Represents the fold increase in inhibition following preincubation of inhibitor reaction with
NADPH.
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3.2.2. Binding of deltamethrin and bifenthrin analogues
In P450s at least one of the following three MBI mechanisms usually predominates; (i) 
N-alkylation of the P450 prosthetic heme moiety; (ii) direct alkylation of the 
apoprotein at the active site; and (iii) chemical-induced heme modification of the 
protein at the active site. However, these mechanisms could all also operate 
concurrently to contribute to some extent to the overall inactivation process (He et al., 
1996). To investigate the binding affinity and the irreversible inactivation mechanism 
of CYP6P3 by C3 and C4, their affinity and binding mode with CYP6P3 was studied. 
This was determined by measuring changes in the optical difference spectra upon 
addition of the compounds to K coli membranes expressing CYP6P3 according to 
McLaughlin et al (McLaughlin et al, 2005). CYP6P3 showed a Hype P binding 
spectrum upon C3 and C4 additions with hnax and bnm of -390 nm and ~420 nm 
respectively (Figure 3.2.A). This type of spectral change is well known to be 
associated with a change from a low spin (hexa-coordinated) state to a high spin 
(penta-coordinated) state of the ferric iron caused by substrate binding.
Spectral differences vs. concentration also plotted to calculate the apparent dissociation 
constant Kd for each compound (Figure 3.2.B). The estimated Kd values for C3 and C4 
were 30 and 24 pM respectively, a fairly modest affinity suggestive of substrate 
interaction with CYP6P3. In general, these observations suggest that these molecules 
might be substrates for CYP6P3.
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3.2.3. HPLC metabolism study
To determine if the deltamethrin and bifenthrin analogues containing the 2POX group 
were CYP6P3 whither degraded upon enzyme activation or not, they were incubated 
with CYP6P3 and the products examined by HPLC. Substrate depletion after 
incubation for 30 minutes +/- NADPH was measured by HPLC using isocratic 
separation conditions. A decrease in substrate concentration was observed with ~ 65% 
and 76% elimination of the initial concentrations of C3 and C4 respectively. The 
metabolites were separated by gradient HPLC. Several metabolite peaks were resolved 
for C3 and C4. These data demonstmte that both C3 and C4 are metabolised by 
CYP6P3 (Figure 3.3). Although metabolism at the alkyne group is needed for MBI, 
P450s often have multiple sites of attack which might affect the efficiency of 
inhibition.
Summing up, both spectroscopic analysis and the HPLC metabolism profile for C3 and 
C4 indicated that while they were substrates for CYP6P3, a prerequisite for MBI, there 
were multiple degradation products, thus the mechanism of inactivation appears 
complex.
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Figure 3.3. HPLC chromatograms of CYP6P3 reactions with C3 and C4. Overlaid 
reaction traces after 30 min of incubation in absence of NADPH (Black) and presence 
of NADPH (blue) showing substrate elimination in the presence of NADPH. Putative 
NADPH-dependant metabolite peaks are indicated by arrows. Red arrows refer to 
consistent and identical retention time metabolite peak generated from two different 
substrates (C3 and C4).
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3.2.4. Modelling of deltamethrin analogues binding to CYP6P3
To help rationalize the experimental data, computational docking studies were 
performed using a CYP6P3 model (Stevenson et al, 2011). In silico modelling studies 
for C3 with CYP6P3 were used to try predicting the key acetylenic pyrethroid-active 
site interactions and to inform on how the molecule might be metabolised leading to 
enzyme inactivation. The most positive binding solution for C3 is shown in (Figure 
3.4).
The phenyl propargyl ether group of C3 reduces the length of the molecule so that the 
molecule may bind in a more favourable position for the metabolism at the ester bond. 
For example the high ranking binding mode of C3 represented in Figure 3.4 shows the 
alpha carbon close to the heme with binding free energy -41.1 Kcal. mol \ suggesting 
metabolism of the ester bond in C3, this may partly explain the metabolism profile that 
was experimentally observed for C3 and C4. However, C3 can bind in three poses; it 
can bind for hydroxylation with binding free energy -38.2. Kcal. mol"1, metabolism on 
the external carbon of the acetylene group -39.5 Kcal. mol"1; and can bind with the 
cyano group close to the heme for either coordination or metabolism of the alpha 
carbon binding free energy -41.1 Kcal. mol'1.
The molecules C3 and C4 are alpha cyano analogues of deltamethrin and bifenthrin, 
thus it is possible that CYP6P3 can attack these molecules from the alpha carbon site 
which might lead to ester hydrolysis for both compounds. This would be similar to 
deltamethrin metabolism by CYP6AA3 (Boonsuepsakul et al, 2008) and CYP6M2 
(Stevenson et al, 2011). The lack of the second aromatic ring (ring B) may increase 
the chance of alpha carbon oxidation by P450 leading to ester hydrolysis. The
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metabolic profile of deltamethrin metabolism by CYP6M2 (see figure 1.5, chapter 1) 
further supports this hypothesis whereby the ipso substitution encourages ester 
hydrolysis of 4' hydroxylated deltamethrin (M4, figure 1.5, chapter l)primary 
metabolites (Stevenson et al, 2011). However further characterisation of the 
metabolites generated by CYP6P3 is needed to validate this hypothesis.
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3.2.5. Rational design of pyrethroid ABPP
The inhibitory effect of arylalkyne ethers including lEPh, 2POX and biphenyl-alkyne 
(2EMe) compounds was confirmed by the irreversible inhibition of RLM and CYP6P3 
(Chapter II). Furthermore, deltamethrin and bifenthrin analogues containing 2POX 
alcohol moiety were also proved to be MBIs for CYP6P3, although their mechanism is 
complex. Therefore, these compounds were used as the basis for the design of 
pyrethroid mimicking ABPPs. Important design considerations were:
1. The arylalkyne ether group was central to the ABPP design due to its structural 
similarity to the common 3-phenoxybenzyl alcohol moiety found in commercial 
cyano pyrethroids (i.e Type 2) such as deltamethrin, cypermethrin and the noncyano 
pyrethroid (i.e. Type 1) pennethrin.
2. What number of benzene rings to use in the aiyl ether and what position to substitute 
the ethynyl group (i.e 2' or 4' position in the B ring, the major sites of P450 attack in 
pyrethroids).
3. Whether the position for optimal access to the click handle (ethynyl group) should 
be in the middle of the molecule replacing the alpha-cyano group or in the terminal 
position in the acid moiety replacing bromine atoms (Figure 3.5).
As a structural model of CYP6P3 was available (Stevenson et a/, 2011), the probes 
were subjected to docking experiments to try and predict the optimal compounds and 
binding modes for successful P450 inactivation or productive binding mode. A binding 
energy term was used for investigating the potency of these compounds in silico. The 
productive mode was considered to be the binding posture that produced close
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Acid Alcohol
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Tag Free Click Chemistry ABP Probes Design
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Non-halogenated Probes
P4S
o
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Figure 3.5. Conversion of deltamethrin (pyrethroid Insecticide) structure into an 
activity based protein pyrethroid (ABPP) probes. The primary sites of deltamethrin 
oxidation are indicated by black arrows and minor sites by open arrows. Deltamethrin 
conversion to ABPP requires addition of warhead and click handles. The structures of 
pyrethroid ABPPs are shown. Red alkyne groups are reactive warheads for P450 
inactivation; blue alkyne groups are the click reaction handles for azide reporter fusion 
and P450 detection. The probes on the left have click handle replacing the bromide 
atoms, while on the right it replaces the CN group.
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proximity of the acetylene terminal carbon to the prosthetic heme-Fe of the enzyme 
that might lead to P450 activation and mechanistic inactivation. Those productive 
binding modes with lowest binding energies were taken to represent highest potency 
and therefore labelling activity against P450s.
3,2,6. Modelling of pyrethroid ABPP probes binding to CYP6P3
The most productive binding modes of pyrethroid ABPPs docked into CYP6P3 model 
are represented in Figure 3.6 and 3.7. In the bromine click-handle substituted probes, 
i.e. P4S, P6S and P9S, P4S is predicted to have a binding mode with the lowest 
binding free energy (AG-48.71 Kcal.mol'1) (Figure 3.6). However, while this places the 
alcohol group above the heme, the external reactive carbon on the acetylene at the 4’ 
position is distant from the reactive Fe centre.
In contrast, the terminal acetylene in the 2' position in P6S points to the Fe atom and is 
in the best position for oxidation. The modelling also suggests that when the B phenyl 
ring is replaced by 1-propyne, the binding score for probe 9S drops as this probe has 
the highest binding free energy -37.94 Kcal mol"1. Additionally the probe P9S 
represented backward binding mode where the alpha cyano group positioned in close 
proximity to iron center. This interesting posture might be due to the lack of bromine 
atoms in the probe structure that seems important for lipophillic interaction with 
phenylalanine residue. This argue may be justified by the fact that probe PI OS stack 
with phenylalanine residue due to lipophillic interaction with bromine atoms which 
leads to binding posture for the acetylene close to heme center (Figure 3.7). 
Interestingly found that this kind of interaction commonly observed for all probes
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containing bromine atoms including probes P7S, 8S and 10S, where the click-handle 
replaces the CN group. However probes P8S (2' warhead substitution) and P7S (4’ 
warhead substitution) have produced a good scoring productive modes i.e. terminal 
carbon positioned on acetylene in a reactive position relative to Fe (Figure 3.7).
Likewise P9S the replacement of benzene ring B by 1-propyne producing PI OS is 
predicted to reduce the binding energy. Comparisons of the predicted binding energies 
suggest that the presence of bromine atoms enhances probe binding. Thus probes P7S 
and P8S were considered to be the best probes for CYP6P3 binding and metabolism. 
In conclusion to further validate the in silico results of the ABPPs probes, the best 
candidates, i.e. P4S, P6S, P7S and P8S were taken forward for chemical synthesis (see 
chapter 4).
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3.3.Materials and methods
3.3.1. Chemicals and reagents
Pyrethroid analogues were kindly given by Professor Paul O' M Neill, Chemistry 
Department, Liverpool University. All solvents were HPLC grade solvent from Fisher 
(UK).
3.3.2. Instrumentation
P450 spectral analysis was carried out using Cary 4000 UV-Vis spectrophotometer 
(VARIAN, UK). Luminescent measurements (P450 Glo-assay) were carried out using 
the multiwall plate reader LUMIstar Omega (BMG Laboratories, UK)
3.3.3. Preparation of E. coli membranes expressed CYP6P3
CYP6P3A4gCPR membranes and inhibition studies were as described in Chapter 2.
3.3.4. Pyrethroid analogues spectral binding studies
Inhibitors binding was measured by optical difference spectroscopy of CYP6P3 
membrane co-expressed with^tgCPR, Membranes were diluted in 100 mM potassium 
phosphate buffer, pH 7.4, to a final concentration of 0.5 pM P450 and split into two 
matched 0.5.ml black-walled quartz cuvette. After running a base line, Ipl aliquots of 
C3 and C4 dissolved in acetonitrile were added to the sample cuvette and equal 
volume of acetonitrile to the reference cuvette.
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The samples were left for 2 min between additions to equilibrate, and the difference 
spectrum was then run between 360-460 nm. The final volume of the inhibitor 
additions was kept to less than 2.5% of the total volume. Changes in absorbance as 
a function of inhibitor concentration, at wavelengths selected on the basis of the 
spectral characteristics of the individual sample, were used to calculate binding 
constants using non-linear regression analysis (Graph pad Prism). Spectral 
determinations were performed and found to be reproducible with respect to the 
spectral profile and the position of Xmax and Xmin.
3.3.5. Pyrethroid metabolism assay
The metabolism assays of pyrethroid analogues were carried out with 
CYP6P3/AgCPR membranes according to the method of Mueller et al 2008, with 
some modifications. Briefly; a concentration of 20 pM deltamethrin and bifenthrin 
analogues (C3 and C4) were incubated with 0.25 pM CYP6P3 in 0.2 M Tris. HC1, pH 
7.4, 0.25 mM MgCl2 in the presence or absence of an NADPH generating system (1 
mM glucose-6-phosphate (Melford), 0.1 mMNADP+ (Melford), 1 unit ml-1 glucose-6- 
phosphate dehydrogenase (G6PDH, Sigma)) in a total volume of 100 pi. Reactions 
were carried out in triplicate at 30°C with 1,200 rpm shaking. Samples were pre­
warmed for 5 min before reactions were initiated by addition of the membrane 
preparation. Reactions were stopped with 100 pi of acetonitrile and incubated for a 
further 20 min to ensure that all pyrethroid was dissolved. The quenched reactions 
were centrifuged at 20,000 g for 10 min before transferring the supernatant to glass 
HPLC vials. 100 pi of the supernatant was loaded onto a mobile phase with a flow rate 
of 1 ml min-1 and 23°C for separation on a 250 mm Cl8 column (Acclaim 120,
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Dionex). Metabolite separations were achieved with a linear gradient from 0% to 90% 
methanol in water (v/v) over the first 6 min, 90% methanol was then held for 10 min 
before returning to 0% with a linear gradient over 2 min followed by equilibration with 
100% water for another 4 min. Pyrethroid elution was monitored by absorption at 
226/232 nm and quantified by peak integration (Chromeleon, Dionex).
3.3.6. P450 modelling and substrate docking
The molecular model of CYP6P3 was created as described by (Stevenson et ah 2011). 
Figures were prepared using PyMOL (v0.99, DeLano Scientific LLC).
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Chapter 4
4. Synthesis of pyrethroid ABPPs 
4.1. Introduction
In this project, a pyrethroid scaffold has been utilised for chemical modification to 
convert it into ABPPs that will enable targeting and identification of P450s that 
metabolise pyrethroids in proteomic specimens le. microsomes. To achieve this 
objective, the alcohol moiety, alpha cyano group and halovinyl groups of a 
deltamethrin scaffold have been used as the basis for chemical modifications (Figure 
4.1).
Initial in silico docking experiments of pyrethroid ABPP probes with the pyrethroid 
metaboliser CYP6P3 predicted that four compounds may have good affinity for 
CYP6P3 (Chapter 3). To enable further characterisation of the designed probes with 
P450s, the aim of this chapter was to synthesis the following pyrethroid ABPP 
structures as illustrated in Figure 4.1; P2, P3R, P4S, P5R,P6S, P7RS and P8RS.
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oType I pyrethroid ABPP probe
Type II pyrethroid ABPP probes 
P3R
Figure 4.1. Chemical structures of pyrethroid mimetic ABPPs. Pyrethroid ABPP 
from P2 to P8 were generated by including the a warhead red acetylene at the possible 
primary site of oxidation and latent click handle blue acetylene group either in the 
middle replacing the alpha cyano group, or at the terminal end replacing the bromine 
atoms.
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4.2. Results and Discussion
The pyrethroid ABPP should have a reactive group for targeting enzyme active sites, a 
binding group for directing the probe to a particular enzyme family, and a latent alkyne 
handle for click chemistry attachment of a reporter group to visualize labelling events 
(Wright et al., 2009). The substitution position of acetylene in the primary site of 
oxidation of deltamethrin scaffold either on 2' or 4' in benzene ring B of 
phenoxybenzyl group was considered in the pyrethroid ABPP design. In addition the 
locality of latent alkynes “click handle” either terminal (replacing halovinyl) or in 
middle of the molecule (replacing alpha-cyano group) has been considered in the probe 
design. In order to append the click handle “alkyne group” in the acid moiety of the 
pyrethroid mimic probes, dibromoalkene (deltamethric acid) was treated with a lithium 
base (w-BuLi) under the basis of Corey-Fuchs reaction (Gibtner et al, 2002) (Scheme 
4.1).
Scheme 4.1. Reaction mechanism of dibromoalkene with w-BuLi
This treatment generates a bromoalkyne intermediate via dehydrohalogenation, which 
undergoes metal-halogen exchange under the reaction conditions and yields a 
reasonable amount of terminal alkyne (60% product yield). The pure product obtained 
was further utilised in preparation of P2, P3R, P4S, P5R and P6S by esterification of 
the acid chloride with aryl alcohol derivatives (Scheme 4.2).
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The ester product was obtained in variable yields between 65-85%. To satisfy aryl 
alkyne (postulated warhead) in type II pyrethroid mimic probes, substitution of an 
acetylene group in X or 4' position of the phenoxybenzyl moiety (alcohol region) were 
carried out following two step intermediates synthesis.
Initial thought was given to the use of palladium-catalyzed cross-coupling reaction of 
the pinacol ester of diboronic acid, with haloarenes as a direct procedure for 
arylboronic esters (preparation named Miyaura borylation reaction (Ishiyama et al, 
1995)). As a next step, the obtained arylboronic esters derivatives can be easily 
coupled to mera-hydroxybenzaldehyde to produce trimethylsilylphenoxy benzaldehyde 
derivatives (Scheme 4.3). Although the reaction was done under the same conditions 
reported in the literature (Ishiyama et ah, 1995) the reaction was unsuccessful and no 
product was obtained.
O
(Step: 1) (Step: 2)
Scheme 4.3. General route of acetylene substituted phenoxybenzaldehyde 
preparation. Step 1 according Miyaura borylation reaction and Step 2 Ulman reaction
Alternatively, direct ether synthesis catalysed by potassium tert-butoxide and DMF 
according to the published method (Albericio et al, 1990; Shan et al, 1997) has been 
followed (Scheme 4.4). However, this was found to give low yield ~5% suggesting
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that this reaction may be much more efficient with aliphatic halides rather than the 
aromatic substituent. Nonetheless, no further improvement has been carried out to this 
reaction.
Scheme 4,4. General schematic of General schematic of acetylated phenoxy 
benzaldehyde preparation
Finally, the trimethylsilyl acetylene substituted phenoxybenzaldehydes were prepared 
via the synthetic route that was preceded into two steps intermediate synthesis 
(Scheme 4.5). The first step of this synthetic route is Chan-Lam Coupling reaction 
(Evans et al.9 1998). The arylation of OH containing compounds phenylboronic acids 
to yield aryl ethers at room temperature is promoted in the presence of cupric acetate 
and a tertiary amine. Beginning with commercially available 2 or 4-iodophenol, 
intermediates 3-(2-iodophenoxy) benzaldehyde and 3-(4-iodophenoxy) benzaldehyde 
were synthesized (Scheme 4.5).
1-3 eq.
ortho or para i eq. cu{oac)2,4a° ms, s eq. 
lodophenol TEA< DCM> atr. RT, 18-36 hrs
Scheme 4.5. Synthetic route to trimethylsilyl acetylene substituted 
phenoxyb enzaldehyde.
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Although the reaction has been reported to be tolerant of a wide range of substituent on 
both coupling partners (Evans et ah, 1998), the yield obtained for our para substituted 
reactant didn’t exceed 30%, and for the ortho substituted starting material reaction 
yield did not exceed 25% with extended reaction time and double the amount of 
phenylboronic acid and catalyst. This finding may be explained by the steric hindrance 
effect of the ortho substituent. No further improvement was made to this reaction as 
the product yield was sufficient to proceed with the next steps.
Following preparation of 3-iodophenoxybenzaldehyde derivatives, the aryl alkyne 
moiety was installed via a Sonogashira coupling reaction (Elangovan et al, 2003) 
producing the trimethylsilyl phenoxybenzaldehyde derivatives (6 and 7) with high 
yield (>95%). This product has been taken forward to prepare compounds 8, 9,10 and 
11 as illustrated in the experimental section. The trimethylsilane protecting group has 
been removed using mild de protection reagent TBAF (Bu4NF) in THF producing 
excellent yields of 8 and 9 >95%. To achieve the cyanohydrins of these intermediate, 
cyanosilylation of aldehydes using trimethylsilyl cyanide and Et3N has been carried 
out with excellent yields (>90 %) of 10 and 11. As a next step trimethylsilyl group has 
been removed by HC1 to produce the corresponding cyanohydrins 12 and 13. The 
cyanohydrins were used directly in the esterification reaction with the acid chloride 
(compound 2), catalysed by pyridine in DCM to produce a diasterioisomeric mixture 
of probes P3R/P4S and P5R/P6S in good yields >60%.
Separation of these diasterioisomer has been achieved by normal phase preparative 
HPLC using gradient of EtOAc in hexane (5-10%) to yield a clear oil of a single
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isomer for each probe. However, it was found difficult to crystallise the separated 
isomers (oil compounds) for identification of their absolute configuration using X-ray 
crystallography. The direct estimation of R and S configuration of alpha cyano product 
using HPLC with chiral column and l]i NMR analysis of methine proton (HCCN) are 
well described in literature (Huang et al, 2005; Jan Gerrits et al, 2001; Tanaka et al, 
1990) and may provide useful approach enable defining the absolute configuration of 
alpha cyano pyrethroids. Here, the same method was adopted to give an approximate 
estimation for absolute configuration of separated diasterioisomers using comparison 
between the downfield shift of 1HNMR of hydrogen proton conjugated to alpha carbon 
(methine) to ester bond and HPLC retention time for separated isomers (Figure 4.2. 
and Figure 4.3). The S isomer of alpha cyano pyrethroid usually displayed higher 
polarity comparing to the R isomer which appear at relatively longer retention time 
(Huang et al, 2005).
Additionally, the diasterioisomer represented different spectroscopic measurements 
^H-NMR) for methine hydrogen proton where S configuration usually represented 
downfield shift comparing to R configuration (Huang et al, 2005). Here in similar 
manner the hydrogen proton of alpha carbon showed two singlets at 5 6.47 ppm (R, on 
HPLC) and 6.42 ppm (S, on HPLC) for probe P3R and P4S respectively (Figure 4.2). 
In similar manner probe P5R and P6S displayed two singlets at 5 6.45 ppm (R) and 
6.42 ppm (S) respectively (Figure 4.3).
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Figure 4.2. Probe 3R and probe P4S a-cyano Alpha cyano isomer separation and 
confirmation by HPLC and 1HNMR. (A) ‘H NMR spectrum (BRUKER 400 Hz) of 
probes 3R and 4S showing the two peaks of the methine proton of probe 3R [6 6.42 (S, 
1H)] and 4S [8 6.47 (S, 1H)] (full NMR spectrum are shown in Appendix). (B) HPLC 
chromatography ot probes 3R and 4S with the following conditions normal phase 
Mobile Phase 5-10% EtoAc in Hexane and separation was carried out at ambient 
temperature and flow rate 5 ml/min. (C) Chemical structure of probes 3R and 4S.
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Figure 4.3. Probe 5R and probe P6S a-cyano isomer separation and confirmation 
by HPLC and 1HNMR. (A) 1H NMR spectrum (BRUKER 400 Hz) of probes 5R 
and 6S showing the two peaks of the methine proton of probe 5R [8 6.42 (S, 1H)] and 
6S [8 6.45 (S, 1H)] (full NMR spectrum are shown in Appendix). (B) HPLC 
chromatography of probes 5R and 6S with the following conditions normal phase 
Mobile Phase 5-10% EtoAc in Hexane and separation was carried out at ambient 
temperature and flow rate 5 ml/min. (C) Chemical structure of probes 5R and 6S.
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The Sonogashira coupling reaction (Elangovan et al, 2003) was also used to install 
alkyne moiety on methyl 6-bromo-2-naphthoate to prepare probe (P2), producing 18 
with excellent yield 90.6%. The product obtained has been reduced to give the 
corresponding primary alcohol 19 using lithium aluminium hydride (LAH), the most 
commonly used reagent for the reduction of esters and carboxylic acids to the primary 
alcohols. Treatment of 19 by TBAF to remove tiimethylsilane protecting group 
produced 20 with excellent yield ~ 95%. This product has been taken forward in the 
esterification step with the acid chloride compound 2 catalysed by pyridine to produce 
the desired probe (P2) with good yield 85% (figure 4.2). Additionally to append the 
click handle “alkyne group” in the middle of the pyrethroid molecule to replace the 
alpha cyano group, trimethylsilyl phenoxybenzaldehyde derivatives were reacted with 
Lithium TMS acetylene at -78° C to achieve 14 and 15 in good yield >50 %. 
Subsequently, the two trimethylsilyl groups were removed in a one pot reaction using 
TBAF which gives 16 and 17 with excellent yield >90%. The probes analogous to 
deltamethrin were prepared in reasonable yield >60% via esterification reaction for 16 
and 17 with acyl chloride of deltamethric acid to gives disterioisomeric mixture of 
probes 7RS and 8RS respectively (Scheme 4.6). Those probes weren’t resolved by 
preparative HPLC even though two different EtOAc gradients at two different 
concentrations has been utilised, suggesting it is best in future to use reverse phase 
HPLC or normal phase chiral columns.
In summary, a suite of pyrethroid ABPPs was successfully prepared; these probes were 
taken forward for validation against mosquitoes P450 enzymes and rodent and 
mosquito microsomes for identification of the P450 enzymes involved in pyrethroid 
metabolism.
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4.3. Experimental
Air and moisture-sensitive reactions were carried out in oven-dried glassware sealed 
with rubber septa under positive pressure of dry nitrogen or argon from manifold or 
balloon. Similarly sensitive liquid and solutions were transferred via syringe, reaction 
were stirred using Teflon coated magnetic stir bars. Organic solutions were 
concentrated using Buchi rotary evaporator with a vacuum pump.
4.3.1. Purification of reagents and organic solvents
Anhydrous solvents were either obtained from commercial sources or dried and 
distilled immediately prior to use under constant flow of dry nitrogen. DCM was 
distilled from CaT^. All other reagents were used as received from commercial sources 
unless otherwise indicated.
4.3.2. Purification of products
Analytical thin layer chromatography was performed with 0.25 mm silica gel 60F 
plates with 254 nm florescent indicator coated aluminium sheets from Merck. Plates 
were visualised by ultraviolet light or by treatment with iodine or potassium 
permanganate followed by gentle heating. Chromatographic purification of products 
was accomplished by flash column chromatography, as described by Still and co 
workers (Still et al, 1978). The high performance liquid chromatography (HPLC) 
(preparative and analytical) was carried out on Gilson HPLC,
4.3.3. Analysis
Nuclear magnetic resonance (NMR) spectra were recorded on a Bmcker AMX 400
1 13( H, 400MHz; C, 100 MHz) spectrometer. Chemical shifts are described in parts per
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million (ppm) downfield from an internal standard of trimethylsilane. Multiplicity are 
recorded as broad peaks (br), singlet (s), doublet (d), triplets (t), quartets (q)3 doublets 
of doublets (dd), doublets of triplets (dt) and multiplets (m). Coupling value are in Hz, 
Mass spectra were recorded on a VG analytical 7070E Machine and Prisons TRIO 
spectrometers using electron ionisation (El), chemical ionisation (Cl) or electron spray 
(ES).
4.3.4. General procedure of intermediate synthesis
O
Deltamethric acid 1
(1R, 3R)-3-ethynyl-2,2-dimethylcyclopropanecarboxylic acid (1) To a stirring 
solution of deltamethric acid (1.49 g, 5 mmol, Bayer Crop Science . Germany) in 25 
ml dry tetrahydrofuran (THF) that has been cooled to -78° C by dry ice acetone bath, a 
solution of 1.6M (11 ml, 17.5mmol, 3.5 equivalent) normal-butyl lithium («-BuLi) in 
hexane was slowly added. The mixture was kept stirring at -78 0 C for 1 hr and then the 
reaction temperature was allowed to rise to room temperature (RT) over next two 
hours under stirring. Thereafter, the reaction was quenched by addition of 20 ml 
double distilled-water and the organic layer was separated. The water layer was 
acidified by 1 M Hydrochloric acid (HC1) to pH 2 and then extracted by 
dichloromethane (DCM) 25ml three times. The organic layer was combined, washed 
with brine and dried with anhydrous Na2S04. Thereafter, all organic solvents were 
removed by vacuum to give the crude product as pale yellow solid which was further
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purified by flash column chromatography eluting with 20-50% Ethyl acetate (EtOAc) 
in hexane to give the product of 1 as a off-white crystal 415 mg (60%).
l:lHNMR (400 MHz, CDC13) 5 = 7.26 (d, J-1.5, 1H), 2.16 (t, .7=12.4, 1H), 1.82 (dt, 
•7=15.8, 7.9, 1H), 1.73 (d, .7=8.6, 1H), 1.39 (s, 3H), 1.22 (s, 3H).13C NMR (100 MHz, 
CDC13) 8 175.26, 79.60, 77.82, 77.74, 77.26,71.43,31.39,27.83,22.94,16.08.
(lR,3R)-3-ethynyl-2,2-dimethylcyclopropanecarbonyl chloride (2) To a solution 
of compound 1 (100 mg, 0.723 mmol) in DCM (25ml), 2.2 equivalent of COCI2 
(157.51 mg, 1.59 mmol) and dimethylformamide (DMF) one tiny drop around 5 pi 
was added. The mixture was kept stirring for at least 3 hrs at RT. After that DCM 
and excess COCI2 are removed in vacuo. The residue was kept under high vacuum 
for at least 2 hrs yielding compound 2 as yellow oil residue. The product was used 
directly without further purification and used in pyridine catalysed esterification 
reaction with primary or secondary alcohol to produce the desired ABPP probes.
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Deltamethric acid
(lR,3R)-3-(2,2-dibromovmyl)-2,2-dimethylcyclopropanecarbonyl chloride (3)
Synthesis achieved using general procedure used for preparation of compound 2 to 
give title compound (3) as yellow oil residue. The product was used directly without 
further purification and used in pyridine catalysed esterification reaction with 
secondary alcohol to produce the desired ABPP probes.
3-(2-iodophenoxy) benzaldehyde (4) and 3-(4~iodophenoxy) benzaldehyde (5) A
mixture of the substrates 4-iodophenol (881 mg, 4 mmol), (3-formylphenyl)boronic 
acid (804mg, 5.2 mmol), 1 equivalent of anhydrous Cu(OAc)2 (734 mg, 4 mmol), - 1 
g of activated molecular sieves (Powdered, 4 A), and 5 equivalent of triethylamine 
(EtsN) (2.79 ml, 20 mmol) in 25 ml DCM was stirred at room temperature for 16 hrs. 
(in the case of using 2-iodophenol as starting material double the amount of (3- 
formylphenyl)boronic acid, Cu(OAc)2, activated molecular sieves (Powdered, 4 A), 
EtsN and DCM were doubled and the reaction time is extended to 30 hours). The
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progress of the reaction was monitored by thin layer chromatography (TLC). When the 
reaction reached completion DCM was removed in vacuo and the residue re-dissolved 
in 30 % EtOAc in hexane and filtered through a pad of silica, washed by 30% EtOAc 
in hexane to give the crude product as pale yellow oil. The crude product was purified 
by flash column chromatography eluting with 10-20% EtOAc in hexane to give the 
desired product (4 and 5).
4: lH NMR (400 MHz, CDCI3) S 9.97 (s, 1H), 7.66 (dd, J= 7.2, 5.2 Hz, 1H), 7.62 (t,./ 
= 6.2 Hz, 1H), 7.51 (dd, J= 14.3, 6.6 Hz, 1H), 7.46 (d, J= 1.9 Hz, 1H), 7.31 - 7.25 
(m, 1H), 6.80 (dd, J= 6.9, 5.0 Hz, 1H).13C NMR (100 MHz, CDCI3) 8 191.84, 158.78 
- 157.55, 156.93 - 156.18, 139.42, 138.58 - 137.83, 131.02, 125.69, 125.19, 121.87,
118.65, 100.33 - 99.58, 87.61 - 87.55, 79.19 - 75.97.
5: ‘HNMR (400 MHz, CDC13) 8 9.97 (s, 1H), 7.66 (dd, J= 7.2, 5.2 Hz, 1H), 7.62 (t, 
J= 6.2 Hz, 1H), 7.51 (dd, J= 14.3, 6.6 Hz, 1H), 7.46 (d, J= 1.9 Hz, 1H), 7.31 - 7.25 
(m, 1H), 6.80 (dd, ./ = 6.9, 5.0 Hz, 1H).I3C NMR (100 MHz, CDCI3) 8 191.84, 
158.78-157.55, 156.93 - 156.18, 139.42, 138.58 - 137.83, 131.02, 125.69, 125.19,
121.87.118.65, 100.33 - 99.58, 87.61 - 87.55,79.19 - 75.97.
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MS
4 or 5
3-(2-((trimethyIsilyl)ethynyl)phenoxy)benzaldehyde (6) and 3-(4-((trimethylsilyl) 
ethynyl)phenoxy)benzaldehyde (7) To solution of 4 or 5 (150 mg, 0.462 mmol) in 
20 ml THF, Cul (1.75 mg, 0.018 mmol, 0.02 eq.), PdCl2 (PPh3)2, (12.63 mg, 0.04 eq) 
and 5 ml Et3N was added and the mixture was degassed. Then 1.3 eq. of 
trimethylsilylacetylene (TMS acetylene, 59.09 mg, 83 pi) was added to the mixture 
and the resulting mixture was degassed again and stirred at RT for overnight. 
Thereafter, all the solvents (THF and Et3N) was removed in vacou, then the residue 
was dissolved in 20% EtOAc in hexane and filtered through a silica pad, washed by 
20% EtOAc in hexane to give the crude products (6 and 7). These were purified by 
flash chromatography 5% EtOAc in hexane to give compound 6 (115 mg, 84.4%) and 
7 (120 mg, 88.2%) of yellow oil.
6: ‘IINMR (400 MHz, CDCI3) 8 9.90 (s, 1H), 7.53 (d,./ = 7.5 Hz, 1H), 7.50 - 7.46
(m, 1H), 7.42 (dd, J= 13.4, 5.7 Hz, 1H), 7.33 - 7.27 (m, 1H), 7.21 (s, 1H), 7.19 (dd, J
= 8.1, 2.5 Hz, 1H), 7.12 (t, J= 7.5 Hz, 1H), 7.01 (d, /= 8.1 Hz, 1H), -0.00 (s, 9H).13C
NMR (100 MHz, CDC13)8 192.52-191.46, 159.36-158.81,156.89-155.83,138.49
- 137.85,135.11 -134.14,130.85-130.21,125.31 - 124.76, 124.67- 124.25,124.13
-123.27,121.29,117.33,101.37-100.73, 100.51 -99.88, 78.98-75.67, 0.00.
7: 'H NMR (400 MHz, CDCI3) 8 9.92 (s, 1H), 7.85 (dd, J= 7.8, 1.2 Hz, 1H), 7.57 (d, J
= 7.5 Hz, 1H), 7.47 (t, J= 7.8 Hz, 1H), 7.35 - 7.32 (m, 1H), 7.32 - 7.28 (m, 1H), 7.24
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- 7.19 (m, 2H), 6.94 (s, 1H), 6.92 (dd, J= 4.5, 3.2 Hz, 1H), -0.00 (s, 9H).13C NMR 
(101 MHz, CDCI3) 5 192.00, 159.23 - 158.10, 140.62, 139.32 - 138.26, 130.97, 
130.40, 126.81, 125.43, 124.42, 120.94, 117.70, 100.93 - 99.00, 91.13 - 88.70, 79.52 
-75.41,1.01--0.74.
(Me)3Si
6 or 7 8 9
3-(2-ethynylphenoxy) benzaldehyde (8) and 3-(4-ethynylphenoxy) benzaldehyde
(9) To a stirring solution of 6 or 7 (110 mg, 0.373 mmol) in 20 ml of THF that was 
cooled to -20° C by dry ice/acetone bath (adjusted to -20 0 by frequent addition of dry 
ice to acetone). Tetra-w-butylammonium fluoride (TBAF, BrqNF, 1.2 equivalents) was 
added by syringe. The mixture was kept stirring at -20°C for 30 min and then the 
reaction is quenched by addition of 20 ml water, and extracted by EtOAc (20x2 ml). 
The organic layer combined and washed by brine and dried using MgS04, after all, 
solvent has been removed in vacuo to give the crude product yellow crystal which 
further purified by flash chromatography eluting with 30% EtOAc in hexane to give 
product 8 (95%) and 9 (96.35%) of pale yellow oil.
8: lK NMR (400 MHz, CDC13) 8 9.98 (s, 2H), 7.64 (t, 6.5 Hz, 1H), 7.54 (t, J= 5.9
Hz, 2H), 7.51 (t, J= 2.0 Hz, 2H), 7.50 - 7.47 (m, 2H), 7.30 (dd, 8.0, 2.5 Hz, 1H), 
7.26 (s, 1H), 6.98 (d, 2.6 Hz, 2H), 6.97 - 6.95 (m, 1H), 3.06 (s, 9H).13C NMR (100
MHz, CDCI3) 5 191.82, 158.05 - 157.68, 157.53 - 156.59, 138.99 - 138.11, 134.42,
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131.04, 125.78, 125.53, 119.25, 118.63 - 117.29, 84.00-82.58, 78.49-76.05, 31.44 
-30.10, 30.10-28.68.
9: NMR (400 MHz, CDC13) 5 9.98 (d, J= 2.2 Hz, 1H), 7.64 (t, J= 7.1 Hz, 1H),
7.54 (t, J= 5.7 Hz, 1H), 7.51 (t, J= 2.2 Hz, 1H), 7.50 - 7.48 (m, 1H), 7.30 (dd, J= 8.1, 
2.6 Hz, 1H), 7.26 (d, J= 2.0 Hz, 1H), 7.00 - 6.97 (m, 1H), 6.98 - 6.95 (m, 1H), 3.07 
(s, 9H).
8 or 9 10 11
2-(3-(2-ethyiiylphenoxy)pheiiyl)-2-((trmiethylsilyl)<)xy)acetonitrile (10) and 2-(3- 
(4-ethynylphenoxy)phenyl)-2-((trimethylsilyl)oxy)acetonitrile (11) To a solution of 
8 or 9 (80 mg, 0.359 mmol) in 10 ml DCM, trimethylsilyl cyanide (TMSCN, 10 eq., 
0.676 ml) and Et3N (0.1, 7.5 pi) were added in. The resulting mixture was kept stirring 
for overnight at RT. After that all of the solvent and the excess TMSCN are removed 
in vacuo to give the product of 10 (110 mg, 78.44%) and 11 (112.2 mg, 80%) as pall 
yellow oil. These compounds were used in the next step without further purification.
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10 or 11 13
2-(3-(2-ethynylphenoxy)phenyl)-2-hydroxyacetoiiitrile (12) and 2-(3-(4-ethynyl- 
phenoxy)phenyl)-2-hydroxyacetonitrile (13) To a solution of 10 or 11 in 10 ml of 
THF, 6 ml of HC1 (2M) was added and the resulting mixture was kept stirring for at 
least 4 hrs after that the reaction mixture was diluted with 15 ml of diethyl ether 
(EfeO). The organic layer was separated and water layer was extracted with Et20 (25
mlx2). Then organic layer was combined and washed with brine and dried with
NazSO^ All of the organic solvents were removed by vacuo to give yellow oil; the 
product was used in the next step without further purification.
or IMS
6 or 7
3“(trimethylsilyl)-l-(3-(2-((trimethylsilyl)ethynyl)phenoxy)phenyl)prop-2-yn-l-ol 
(14) and 3-(trimethylsilyI)-l-(3-(4-((trimethylsilyl)ethynyl)phenoxy)phenyl)prop- 
2-yn-l-ol (15) To a solution of 6 or 7 (120 mg, 0,407 mmol) in THF cooled to -78° C 
in dry ice/acetone bath, a solution of lithium trimethylsilylacetylene (Li-TMSA) in 
THF 1 ml (0.5 M, 1.2 eq) was added slowly and the mixture stirred for 3hours at -78°
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C then the reaction temperature is allowed to raise. When the temperature reaches 0° C 
the reaction is quenched with saturated solution of ammonium chloride (NH4CI), and 
15 ml of Et20 was used to dilute the solution. The organic layer was separated and the 
water layer was extracted with Et20 (25 ml><2). The organic layers was combined, 
washed with brine, and dried with Na2S04, After remove all of the organic solvents in 
vacuo the obtained crude product subsequently was purified by flash column 
chromatography eluting with 10 % EtOAc in hexane, to give the product 14 (87 mg, 
54.4 %) and 15 (80 mg, 50%) as yellow oil.
14:'H NMR (400 MHz, CDCI3) 8 7.34 (dd, J= 7.7, 1.6 Hz, 1H), 7.18-7.11 (m, 1H), 
7.09 (d, J= 2.3 Hz, 1H), 7.07 (d, /= 7.7 Hz, 1H), 6.97 (s, 1H), 6.93 (t, /= 7.5 Hz, 1H), 
6.82 (d, J= 8.1 Hz, 1H), 6.77 (dd, ./= 8.0, 2.2 Hz, 1H), 5.23 (d, J= 6.4 Hz, 1H), 1.88 
(s, 1H), -0.00 (s, 9H), -0.07 (s, 9H).I3C NMR (100 MHz, CDC13) 5 158.33, 142.30, 
134.53, 133.35, 129.97, 130.07, 123.91, 121.21, 120.59, 117.69, 116.70, 116.03, 
77.99,65.64,31.15, 0.00.
ISi'H NMR (400 MHz, CDCI3) 8 7.34 (dd, /= 7.7, 1.6 Hz, 1H), 7.16 - 7.10 (m, 1H), 
7.09 (d, J= 2.3 Hz, 1H), 7.07 (d, J= 7.7 Hz, 1H), 6.97 (s, 1H), 6.93 (t, 7.5 Hz, 1H),
6.82 (d, J= 8.1 Hz, 1H), 6.77 (dd, J= 8.0, 2.2 Hz, 1H), 5.23 (d, J= 6.4 Hz, 1H), 1.88 
(s, 1H), -0.00 (s, 9H), -0.07 (s, 9H).13C NMR (100 MHz, CDCI3) 8 158.33 , 141.74, 
133.96, 133.35, 129.97, 129.76, 123.91, 120.90, 120.13, 117.69, 116.29, 115.83, 
74.45, 64.30, 31.15, 0.00.
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14 or 15 16 17
l-(3-(2-ethynylphenoxy) phenyl) prop-2-yn-l-ol (16) and l-(3-(4-ethynylphenoxy) 
phenyl) prop-2-yn-l-ol (17) Synthesis achieved using general procedure used to 
prepare compounds 8 and 9 with the same scale to give 16 (95%) and 17 (94%) as 
yellow oil residue. There is no further confirmation on the product carried out, but this 
was taken forward for esterification with the acid chloride.
4.3.5. Synthesis of pyrethroid ABPP contains terminal click handle replacing 
halogen atoms.
4.3.5.I. Synthesis of Probe 2
Synthesis of probe 2 was achieved using the general route illustrated below (Figure 
4.2).
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o o
Br
Methyl 6-bromo-2- 
naphthoate
CH3
Methyl 6-((trimethylsilyl) ethynyl)-2-naphthoate (18) A mixture of methyl 6- 
bromo-2-naphthoate (0.541 g, 2 mmol), Cul (7.8 mg, 40 pmol), and the palladium 
catalyst Pd (PPha^C^ (56 mg, 79.78 pmol) were dissolved in EtsN (20 ml) in a dry 50 
ml flask with a stir bar under N2 and fitted with a condenser. The solution was 
dissolved and heated to 90° C for 15 min at which tune 1,3 equivalent TMS acetylene 
(0.37224 ml, 2.6 mmol) was slowly added. The reaction was left on heating at 90 °C 
for overnight (~14 hrs). The solvents were removed in vacuo and the crude residue was 
redissolved in 25 ml DCM. The organic solution was washed with 25 ml x 2 water, 25 
ml 10% citric acid and saturated 25 ml sodium bicarbonate, and brine 10 mlx2. The 
organic layer was dried with anhydrous sodium sulphate, filtered, and removed in 
vacuo. The product was further purified over silica (hexane: EtOAc (19:1)) yielding 18 
(0.512 g, 90.6%) as an off-white solid.
18: ‘H NMR (400 MHz, CDCI3) 5 8.56 (s, 1H), 8.23 - 7.99 (m, 1H), 7.99 (d, / = 
23.1 Hz, 1H), 7.95 - 7.63 (m, 1H), 7.56 (dd, J= 8.5, 1.4 Hz, 1H), 7.54 - 7.27 (m, 
1H), 7.26 (s, 1H), 3.98 (s, 3H), 0.51 - 0.05 (m, 9H).13C NMR (101 MHz, CDCI3) 5 
170.30- 164.24, 135.29- 134.76, 132.06- 131.83, 131.72, 130.80, 129.45, 129.30, 
128.04, 126.00, 123.14 - 122.38, 108.13 - 102.62, 101.28 - 97.98, 98.53 - 91.61, 
79.49-74.06, 52.38, 0.00.
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(6-((trimethyIsilyl)ethynyl)naphthalen-2-yl)methanol (19) To a stining solution of 
18 (500 mg, 1.77 mmol) in THF which has been cooled to 0° C by an ice water bath, 2 
equivalent a solution of lithium aluminium hydride (LiAlH4, 1.013 ml, 3.5M). in 
THF/toluene was added in slowly. The mixture was then kept stirring at room 
temperature for 2 hrs. Thereafter, the reaction was quenched by addition of 10 ml dd 
water and then acidified by HC1 (1 M, 10 ml). The mixture was extracted by EtzO (30 
mlx2) and the organic layer is dried by MgSC>4. After all organic solvent were 
removed, the product 19 was given as yellow solid (364 mg, 80.9%) this product were 
taken forward directly to the next step to prepare 20.
20
(6-ethynylnaphthalen-2-yl) methanol (20) The solution of 19 in 15 ml of THF (364 
mg) which has been cooled to -20° C, 1.1 equivalent of TBAF (1.947 ml) was added 
in. The mixture was kept stirring at -20°C for 30 min and then the reaction was 
quenched with water 20 ml. The resulting mixture was extracted by Et20 (20 mix2) 
and the combined organic layer was washed with brine and was dried by MgS04. All 
of the solvent was removed in vacuo to give the crude product as yellow solid.
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crude product was purified by flashy chromatography eluted with 30% EtOAc in 
hexane to give product 20 (242.9 mg, 94.2%) as pale yellow solid.
20: lK NMR (400 MHz, CDC13) 5 8.02 (s, 1H), 7.84 - 7.78 (m, 1H), 7.77 (s, 1H), 7.56 
-7.51 (m, 1H), 7.49 (d,J= 1.1 Hz, 1H), 7.26 (s, 1H), 4.87 (d, 7= 5.0 Hz, 1H), 3.15 (s, 
2H), 1.57 (s, 1H).13C NMR (101 MHz, CDC13) 8 200.94 - 197.63, 140.05 - 139.81, 
133.48 - 133.28, 132.57 - 132.40, 129.34, 128.62, 128.41, 126.27, 125.60, 101.31 -
98.87, 84.69 - 83.53, 77.55, 65.71.
20 P2
(lR,3R)-(6-ethynylnaphthalen-2-yl)methyl3-ethynyl-2,2-(limetliylcyclopropane- 
carboxylate (P2) The acid chloride (compound 2, (384.16pmol)) dissolved in DCM 
and 2 equivalent of pyridine (30|il) was added in the solution, then reaction proceeds 
by the addition of the solution of compound 20 (1 eq. 70 mg, 384.16pmol ) in DCM. 
The resulting mixture was kept stirring at RT for overnight, when the reaction finished 
the solvent and the excess pyridine were removed in vacou. The residue was dissolved 
in Et20 (50 ml) and was washed by H2O, NaHCOs (satumted) and brine. The crude 
product is purified by flash column chromatography eluting with 5 % -10 % EtOAc in 
hexane to give the product of 100 mgs (85%) as pale yellow crystal.
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P2: ‘H NMR (400 MHz, CDCI3) S 8.01 (s, 1H), 7.80 (s, 1H), 7.79 - 7.75 (m, 1H), 7.52 
(dd, J= 8.5, 1.4 Hz, 1H), 7.46 (dd, /= 8.5, 1.4 Hz, 1H), 7.26 (s, 1H), 4.87-4.76 (dd, 
2H), (d, J= 11.2 Hz, 1H), 3.49 (s, 1H), 3.15 (s, 1H), 2.14 (q, J= 5.6 Hz, 1H), 1.35 (s, 
3H), 1.19 (s, 3H).13C NMR (101 MHz, CDC13) 5 200.30 - 199.63, 190.19 - 189.33, 
174.34-173.78,136.66-136.12,132.66-132.11, 129.59-129.12,128.56,127.20- 
125.79, 121.38 - 118.07, 107.69 - 105.17, 104.07 - 101.63, 85.10 - 83.14, 81.48 - 
79.83, 79.04 - 76.05, 65.59 - 63.93, 39.46 - 36.94, 32.11, 27.89 - 25.69, 21.08,18.77 
-16.56. HRMS (Cl); 303.13909 [M+H]+ C21H19O2 requires 392.13850
43.5.2. Synthesis of probe 3R and 4S
(1R, 3R)-(R)-cyano(3-(4-ethynylphenoxy)phenyl)methyl 3-ethynyl-2,2-dimethyl 
cyclopropanecarboxylate (P3R) and (lR,3R)-(S)-cyano(3-(4-ethynylphenoxy) 
phenyl)methyl 3-ethynyl-2,2-dimethylcyclopropanecarboxylate (P4S) Synthesis 
was achieved using the procedure used for preparation of P2 to give the title 
compound as a yellow oil residue. The crude product was purified by flash column 
chromatography eluting with 5 -10 % EtOAc in hexane to give the product of 80 mg 
(83%) as pale yellow oil of disterioisomers mix of P3R and P4S that was confirmed 
by 1HNMR. Separation of these disterioisomeric has been achieved by normal phase 
preparative HPLC using gradient of as eluent EtOAc in hexane (5-10%) with a flow
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rate of 5 ml min-1 to give P3R ((1R) retention time 52.7 min, 44 mg) and P4S ((IS) 
retention time 57.8 min 31 mg). The absolute configuration of CHCN was related to 
deltamethrin.
P3R: ‘H NMR (400 MHz, CDCL3) 5 7.50 (s, 1H), 7.48 (s, 1H), 7.43 (t, J= 8.0 Hz, 
2H), 7.32 - 7.26 (m, 2H), 7.20 (t, J= 1.9 Hz, 1H), 7.09 (dd, /= 8.1, 2.2 Hz, 1H), 6.97 
(s, 1H), 6.95 (s, 1H), 6.42 (s, 1H), 3.06 (s, 1H),2.11 (d,,7=2.2 Hz, 1H), 1.86(dt,J = 
6.5, 3.3 Hz, 2H), 1.79 (d,,/ = 8.5 Hz, 1H), 1.41 (s, 3H), 1.24 (s, 3H).13C NMR (101 
MHz, CDCI3) 5 167.66 - 167.27, 157.60, 134.30, 131.16, 123.29, 121.18 , 119.15, 
118.79,118.06-117.59,116.62-116.16,83.68 - 83.12,79.58 - 78.63, 77.40, 71.74,
62.44, 30.84, 28.56, 27.55, 23.36, 16.05. HRMS (ESI); 392.1254 [M+Na] + 
C24Hi9N03+Na requires 392.1263.
P4S:1HNMR(400 MHz, CDCI3) 8 7.50 (s, 1H), 7.48 (s, 1H), 7.43 (t, J= 7.9 Hz, 1H), 
7.33 - 7.26 (m, 1H), 7.20 (d, J= 1.9 Hz, 1H), 7.09 (dd,./ = 8.1, 2.3 Hz, 1H), 6.97 (s, 
1H), 6.95 (s, 1H), 6.47 (d, J= 19.0 Hz, 1H), 3.06 (s, 1H), 2.15 (d, J=2.2Hz, 1H), 1.89 
(dt, J= 12.2, 6.1 Hz, 1H), 1.79 (d, J = 8.6 Hz, 1H), 1.34 (s, 3H), 1.20 (s, 3H).13C NMR 
(101 MHz, CDCI3) 8 167.64 - 167.34, 157.78 - 157.22, 134.37, 131.17, 123.32, 
121.15, 119.17, 118.80 , 118.38 - 117.65, 116.56 - 116.14, 83.58 - 83.10, 79.09 -
78.45, 77.41, 71.91, 62.51, 30.86, 28.32, 27.51, 23.41, 16.08.HRMS (ESI); 392.1257 
[M+Na]+ Ca+HisNOs+Na requires 392.1263.
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4.3.5.3. Synthesis of probe 5R and 6S
12 Mixture of P5R and P6S
(lR,3R)-(R)-cyano(3-(2-ethynylphenoxy)phenyl)methyl 3-ethynyl-2,2-dimethy 
Icyclopropanecarboxylate (P5R) and (lR,3R)-(S)-cyano(3-(2-ethynylphenoxy) 
phenyl) methyl 3-ethynyl-2,2-dimethylcyclopropanecarboxylate (P6S)
Synthesis was achieved using the procedure used for preparation of P2 to give title 
compound as yellow oil residue. The crude product was purified by flash column 
chromatography eluting with 5 -10 % EtOAc in hexane to give the product of 61 
mg (63%) as pale yellow oil. The product was further purified by preparative 
HPLC to give of white clear oil. Separation of these diastermoers has been 
achieved by normal phase preparative HPLC using eluent gradient of EtOAc in 
hexane (5-10%) with a flow rate of 5 ml min'1 to give P5R ((1R) retention time 
43.1 min, 32mg) and P6S ((IS) retention time 46.2 min, 28 mg). The absolute 
configuration of CHCN was related to deltamethrin.
P5R: ‘HNMR (400 MHz, CDC13) 8 7.57 (dd, J= 7.7,1.6 Hz, 1H), 7.40 (t, J= 8.0 Hz, 
1H), 7.34 (dt, J= 13.1, 2.7 Hz, 1H), 7.26 (t, J= 6.3 Hz, 1H), 7.19 (t, 7= 3.7 Hz, 1H), 
7.14 (t, J= 7.5 Hz, 1H), 7.05 (dd, J = 8.2, 2.3 Hz, 1H), 6.94 (d, 7= 8.3 Hz, 1H), 6.42 
(s, 1H), 3.22 (s, 1H), 2.12 (d, 7= 2.2 Hz, 1H), 1.86 (dd, 7= 8.5, 2.2 Hz, 1H), 1.79 (d, 7 
= 8.5 Hz, 1H), 1.41 (s, 3H), 1.24 (s, 3H).13C NMR (101 MHz, CDCI3) 5 167.52, 
158.15, 157.69, 134.92, 133.95, 130.91, 124.51, 122.82 , 120.35, 119.70, 118.15,
120
116.46, 115.30, 82.66, 79.23, 78.42-76.43, 71.77, 62.51, 30.84, 28.53,27.55, 23.32, 
16.07. HRMS (ESI); 392.1259 [M+Na]+ Ci-iHisNOs+Na requires 392.1263
P6S: ‘H NMR (400 MHz, CDC13) 6 7.57 (dd, 7= 7.7, 1.5 Hz, 1H), 7.45 - 7.38 (m, 
1H), 7.34 (dt, J= 12.5,2.4 Hz, 1H), 7.27 (dd, 7= 9.0, 6.0 Hz, 1H), 7.18 (d, J= 2.0 Hz, 
1H), 7.14 (t, J= 7.5 Hz, 1H), 7.08 - 7.02 (m, 1H), 6.94 (d, 7= 8.3 Hz, 1H), 6.45 (s, 
1H), 3.21 (s, 1H), 2.16 (d, 7= 2.3 Hz, 1H), 1.89 (dd, 7= 8.5, 2.2 Hz, 1H), 1.79 (d, 7= 
8.6 Hz, 1H), 1.34 (s, 3H), 1.20 (s, 3H).13C NMR (101 MHz, CDC13) 5 167.49, 158.17, 
157.65, 134.93, 134.20, 130.92 , 124.56, 122.85, 120.36, 119.74, 118.08, 116.41, 
115.32, 100.28-99.73, 82.63,79.35,78.99,78.29-76.54,71.91, 62.55,30.86,28.33, 
27.53, 23.38, 16.09. HRMS (ESI); 392.1246 [M+Na] + C24H19NO3+ Na requires 
392.1263.
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4.3.6. Synthesis of pyrethroid ABPP probes containing click handle
replacing the alpha cyano group. 
4.3.6.X. Synthesis of probe 7RS
(1R, 3R)-l-(3-(4-ethynylphenoxy) phenyl) prop-2-yn-l-yl 3-(2,2-dibromovinyl)-2,2 
—dimethylcyclopropanecarboxylate (7RS) Synthesis achieved using procedure used 
for preparation of P2 to give title compound as yellow oil residue. The crude product 
was purified by flash column chromatography eluting with 5 -10 % EtOAc in hexane 
to give the product of 80 mg (83%) as pall yellow oil. The product is further purified 
by preparative HPLC to give isomer mix of white clear oil 70 mg (72%). lR NMR 
(CDC13) confirmed a mixture of two isomer pairs.
lK NMR (400 MHz, CDC13) 8 7.47 (dt, J= 6.8, 2.4 Hz, 1H), 7.38 (tt, J= 8.2, 4.1 Hz, 
1H), 7.32 - 7.27 (m, 1H), 7.26 (d, J= 3.9 Hz, 1H), 7.22 (dd, J= 10.4, 1.9 Hz, 1H), 
7.03 - 6.98 (m, 1H), 6.95 (dt, </= 6.7, 2.4 Hz, 1H), 6.75 (t, 8.0 Hz, 1H), 6.40 (dd,
/= 12.7, 2.1 Hz, 1H), 4.18 - 4.05 (m, 1H), 3.08 (d, J= 24.9 Hz, 1H), 2.66 (dd, J = 
5.7, 2.3 Hz, 1H), 1.96 (ddd, J= 32.4, 17.7, 8.4 Hz, 6H), 1.26 (ddd, /= 22.8, 17.2, 
12.2 Hz, 6H). HRMS (ESI); 550.9639 [M+Na] + C2sH2oBr203+ Na requires 
550.9656.
122
4.3.6.2. Synthesis of probe 8RS
P8RS
(lR,3R)-l-(3-(2-ethynylphenoxy) phenyl) prop-2-yn-l-yl 3-(2,2-dibromovinyl)- 
2,2 -dimethylcyclopropanecarboxylate (P8RS) Synthesis achieved using procedure 
used for preparation of P2 to give title compound as yellow oil residue. The crude 
product was purified by flash column chromatography eluting with 5 -10 % EtOAc 
in hexane to give the product of ~60 mg (62 %) as pall yellow oil. The product is 
further purified by preparative HPLC to give isomer mix of white clear oil 53 mg 
(55%). ^ NMR (CDC13) confirmed a mixture of two isomer pairs.
‘H NMR (400 MHz, CDC13) 8 7.56 (dd, J = 7.7, 1.4 Hz, 1H), 7.39 - 7.33 (m, 1H), 
7.30 (d, J= 8.7 Hz, 1H), 7.26 (s, 1H), 7.23 (dd, J= 11.1, 1.9 Hz, 1H), 7.10 (t,J= 7.5 
Hz, 1H), 6.99 (d, 7= 8.1 Hz, 1H), 6.90 (d, J= 8.0 Hz, 1H), 6.75 (dd, J= 8.3, 5.9 Hz, 
1H), 6.40 (dd, J= 13.7, 2.2 Hz, 1H), 4.12 (dd, J - 14.3, 7.1 Hz, 1H), 3.22 (d, J = 1.9 
Hz, 1H), 2.65 (dd, J= 5.6, 2.3 Hz, 1H), 2.01 - 1.84 (m, 6H), 1.33 - 1,15 (m, 6H). 
HRMS (ESI); 550.9634 [M+Na] + C25H2oBr203+Narequires 55
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Chapter 5
5. Validation of pyrethroid ABPP probes
S.l.Introduction
The development of a novel tool to enable the direct and selective identification of 
P450’s that actually metabolise pyrethroids and represent potential metabolic 
resistance markers was the principal objective of this PhD project. Having designed 
and synthesised pyrethroid based clickable activity based protein profiling probes 
(ABPPs) (Chapters 3 and Chapter 4), the next step was to determine which, if any, 
were capable of selectively labelling pyrethroid metabolising P450s in microsomes. To 
do this the specificity and selectivity of the suit of novel pyrethroid ABPPs were tested 
against E. coli membranes expressing individual Anopheline pyrethroid metabolising 
P450s CYP6P3, CYP6M2 and non pyrethroid metabolising control, CYP6Z2.
Next, the pyrethroids ABPPs were evaluated for their ability to identify relevant 
pyrethroid metabolisers in microsomes extracted from rodents and mosquitoes. 
Finally, the identity of proteins selectively pulled down by the probes were examined 
to determine the power of ABPPs in the selective tagging, detection, enrichment, and 
identification of the key enzymes involved in pyrethroid metabolism in their native 
membrane environment.
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5.2.ResuIts and Discussion
5.2.1. NADPH dependent inhibition of P450s by ABPP Probe 2 (P2)
To test whether pyrethroid ABPPs can label P450s in an activity-dependent
manner, preliminary inhibition testing of P2 against the pyrethroid metabolisers 
CYP6M2 and CYP6P3 was carried out using P450-Glo assay (Promega, UK). As 
shown in Figure 5.1. NADPH dependent inhibition was demonstrated for CYP6P3 but 
not CYP6M2. P2 was taken forward for further characterisation i. e. visual detection of 
P450-probe adducts by click chemistry and azide reporter attachment.
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-NADPH 
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CYP6P3
[P2] |iM
Figure 5.1. Residual activity of CYP6M2 and CYP6P3 after treatment with 
different concentrations of P2. Different concentrations of P2 (10, 100 and 200 jaM) 
were pre-incubated with 0.2 pM P450 in the presence and absence of 1 mM NADPH 
before measuring the residual enzyme activity by addition of the probe substrate 
PPXE. Note, the pre-incubation reaction was diluted 10 fold into the PPXE probe 
reaction mix to minimize the interference from ABPP carry-over.
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5.2.2. Labelling of P450s with P2
5.2.2.X. Western blot detection of activity based P450-P2 adduct formation.
Initial characterisation of CYP6P3 labelling by pyrethroid ABPP probe (P2) 
was earned out using standard Western blotting and chemiluminescent detection 
(ECL). It was hoped that the biotin azide labelled P450 would be detected by avidin 
labelled horseradish peroxidise, resulting in an ECL detectable band. NADPH 
dependent labelling was observed at the region of 49 and 55 KDa, the size expected 
for P450s (Figure 5.2), however, labelling was weak with high background even after 
dilution of avidin horseradish peroxidase to 1:50000, or after precipitation of labelled 
protein and cold methanol washing to concentrate and remove excess click reagents. 
The low sensitivity and non specific binding made this system unsuitable for 
comparative profiling of the reactivity of pyrethroid ABPP probes with P450 enzymes.
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+ - + NADPH
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ladder
X-ray film Nitrocellulose membrane
Figure 5.2. Western blots for detection of CYP6P3 labelling by probe 2. The
CYP6P3 membrane normalised to 0.2 fiM and incubated with probe 2 at 10 pM in 
presence and absence of NADPH at 37° C. Following 1 h incubation, proteomes were 
treated with an azide-conjugated biotin tag under CC conditions and resolved by SDS- 
PAGE. The labelled protein was transferred by electro blotting (semi dried) onto 
nitrocellulose membranes and detected by blot treatment with an avidin-horseradish 
peroxidase conjugate, following membrane blocking by 3 % BSA. The super signal 
chemiluminescence reagents (Thermo, UK), were used to detect the labelling event. 
The relative amounts of pyrethroid probe-biotin labelling were estimated by film 
densitometry. The NADPH-dependent probe-labelled proteins were detected at ~ 
49KDa, consistent with the molecular masses of P450 enzymes.
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S.2.2.2.1D-Gel fluorescence analysis
To overcome the high background caused by non specific binding of biotin-azide and 
low sensitivity of the Western blot detection, a ID-Gel fluorescence scanning 
technique was used for comparative profiling of pyrethroid ABPPs. An initial 
experiment with CYP6P3 and CYP6M2 was carried out to investigate the reactivity of 
P2 with recombinant P450s. This probe was added to P450 membranes co-expressed 
with AgCPR in the presence or absence of NADPH. Following 1 hr incubation, 
membranes were treated with an azide conjugated Alexa Fluor® 488 tag under CC 
conditions and resolved by SDS-PAGE. The green-fluorescent Alexa Fluor® 488 
azide was chosen for its azide reactivity with terminal alkynes via a copper-catalyzed 
click reaction (Speers et al., 2003). In addition to being an exceedingly bright and 
photostable fluorophore (low photo-bleaching), Alexa Fluor® 488 azide is soluble in 
water and stable at different pH levels which makes it remarkably adequate to use in 
different applications and different conditions.
The in-gel fluorescence scanning experiments identified an intensely labelled protem 
band in the range of 48-55 kDa, which was only observed in the NADPH-treated 
sample (Figure 5.3). Interestingly, consistent with the lack of MBI against CYP6M2, 
P2 clearly showed NADPH dependent labelling of CYP6P3 but not CYP6M2.
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Laser imaged
Coomassie
stained
6M2 6P3
i
Probe 2
X
Figure 5.3. Probe reactivity profiles with CYP6M2 and CYP6P3. Selective 
labeling of P2 by in-gel ID fluorscence analysis. CYP6M2 and CYP6P3 membranes 
were incubation of P2 (10 ^M) with 0.2 pM P450, Only CYP6P3 was labelled in the 
presence of NADPH Coomassie staining of the gel confirms equal loading of samples 
+/- NADPH
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5.2.2.3. Optimisation of probe conditions
Titration of P2 with CYP6P3 was carried out to determine the optimum concentration 
of probe and AlexaFluor® 488 azide reporter. As shown in Figure 5.4, the labelling of 
CYP6P3 was dependent on probe concentration, and the NADPH dependent labelling 
intensity increased with increasing concentration of Alexa Fluor® 488 azide from 25 
pM to 100 pM. However, the increasing background labelling occurred in the absence 
of NADPH treatment at high reporter concentrations of the reporter even after fixing 
and copious washing (gel washed overnight in destaining solution).
The background could be removed by protein precipitation and washing by cold 
methanol following click reaction to remove the excess click reagents. However, this 
was found to alter the protein concentration slightly (Figure 5.4.C). This may affect the 
comparative interpretation of paired samples. Therefore, it was decided to use Alex 
Fluor 488 azide at low concentration (25 pM) in combination with gel destaining to 
reduce the background.
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5.2.3. Pyrethroid ABPP labeling of An. gambiae P450s
To determine the selectivity and specificity of ABPPs against pyrethroid metabolising 
enzymes, the suite of pyrethroid probes were screened against three An. gambiae 
recombinant P450s CYP6M2, CYP6P3 and CYP6Z2. The former two being enzymes 
that can metabolise deltamethrin and permethrin and are associated with pyrethroid 
resistance in An. gambiae (Muller et al, 2008) while CYP6Z2, although associated 
with pyrethroid resistance, does not metabolise pyrethroids (McLaughlin et al, 2008). 
To profile the activity of the P450, the ABPP panel were incubated at a fixed 
concentration of 20 pM with 0.2 pM P450 at 37°C in the presence and absence of 
NADPH.
As expected the general substrate control probe, PI, labelled the three P450s. The 
probe labelling was also clearly NADPH dependent, proving the reaction had worked. 
In general, the ABPPs show quite widely variable reactivity and selectivity against the 
three P450s (Figure 5.5). Most of the P450 enzymes were labelled by multiple probes, 
however strong reactivity was clearly displayed by the probes containing bromine 
atoms i.e. P7RS and P8RS. This appears consistent with the relatively low binding 
energies calculated in Chapter 3 for these probes in the CYP6P3 model. This 
reinforces the role of the bromine atom in binding and further suggests that the 
deltamethrin like ABPPs are the strongest P450 binders. It was notable that not all 
reactions were NADPH dependent, with high background particularly evident with 
CYP6P3 and P7RS (Figure 5.5)
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The differences in P450 reactivity profiles were quantitatively assessed by measuring 
the intensity of each CYP-probe labelling event using in-gel fluorescence scanning as 
depicted in Figure 5.6A. To ensure that these measurements reflected activity-based 
labelling of P450 enzymes, the —NADPH control signals were subtracted and 
calculated as differences in fluorescent intensity of P450 bands in reactions with or 
without NADPH according to Wright et at, (Wright et at, 2009). These measurements 
were used to devise a more complete presentation of labelling profiles for the P450 
panel as a heat-map (Figure 5.6B).
The heat map revealed cleaner differences in probe—P450 reactivity profiles allowing 
the selectivity of the probes to be more clearly assessed. P7RS only recognised 
CYP6M2, thus selective for the resistance marker. P2 and P3R recognised both the 
pyrethroid metaboliser, CYP6P3 and CYP6M2, indicating a potential broad preference 
for pyrethroid metabolising enzymes. Finally, P8RS, and P5R displaying a broad 
reactivity against all three the enzymes, similar to PI.
Interestingly, the ability to distinguish stereospecific differences was displayed by the 
optical enantiomer pairs P4S and P3R, where P3R labels CYP6P3 but P4S does not. 
CYP6P3 was noticeably darkly stained with probe P7RS but did not show NADPH 
dependent labelling (Figure 5.5). Subtraction of the -NADPH control for the heat map 
(Figure 5.6) produced a blank value, suggesting non specific probe binding, or perhaps 
tight binding in absence of NADPH. Similar reasons may be applied to P7RS labelling 
of CYP6Z2 in the absence of NADPH.
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5.2.4. Removal of —NADPH background bands
In order to try and overcome the background labelling, affinity purification of 
CYP6P3 labelled with P7RS was done following the click reactions (presence and 
absence of NADPH) using a rhodamine-trifunctional biotin azide reporter(Speers and 
Cravatt, 2004b). This reporter contains a biotin group which enables enrichment of 
biotin labelled protein using streptavidin agarose beads following click reaction, while 
rhodamine provides fluorescent detection of labelled proteins resolved by ID-Gel. As 
shown in Figure 5.7, the affinity step was successful in cleaning-up the background. 
Overall, these experiments proved that the ABPPs work and that affinity purification 
of reaction products can enhance the sensitivity of the technique by removing 
background binding. The next step was to determine if the probes were capable of 
identifying pyrethroid metabolising P450s in their native microsomal environment.
NADPH+
49 KDa
Figure 5.7. Enrichment of NADPH dependent CYP6P3 labelled by probe P7RS.
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5.2.5. In vitro labelling of P450s from different species
To confirm the suitability of the pyrethroid ABPPs for the detection of pyrethroid 
metabolising enzymes in a native proteome context, the pyrethroid ABPPs tested 
against microsomes prepared from different species ie. adult An, gambiae, rat and 
mouse liver.
5.2.5.1. Mouse liver microsomes
For initial profiling, four pyrethroid ABPP probes were tested against mouse liver 
microsomes. These were P2, the type I pyrethroid mimic probe, P3S, P7RS and P8RS, 
the type II pyrethroid mimic probes, and PI, the general ABPP control probe known 
to react with mouse liver microsomes (Wright and Cravatt, 2007; Wright et al.9 2009). 
As shown in Figure 5.8A, a band in the P450 region was detected by all four 
pyrethroid ABPPs, as well as with the PI control probe. Thus, NADPH dependent 
labelling of P450s (ie. activity based) was clearly evident, the halogenated probes 
including P7RS and P8RS producing strongest signals. These are of particular interest 
as they mimic deltamethrin, the most widely used pyrethroid insecticide.
5.2.5.2. Rat liver microsomes
These were heated with P7RS, the type 2, deltamethrin mimic probe and the type I non 
cyano pyrethroid mimic probe, P2. The probes displayed differential reactivity against 
rat liver microsomes, but again the labelling intensity was much higher with 
deltamethrin mimic probe P7RS containing bromine atoms (Figure 5.8B).
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5.2.S.3. Mosquito microsomes
Microsomes (2 mg/ml) were prepared from An. gambiae mosquitoes (2-3 day old adult 
females) from both a pyrethroid resistant strain collected from Uganda (Tororo strain) 
(Ramphul et al, 2009) and a laboratory susceptible strain (Kisumu). They were 
screened with P7RS, chosen because of its structural similarity to deltamethrin and its 
high reactivity with CYP6M2 and CYP6P3, as well as for its high activity with mouse 
and rat liver microsomes. Because of the low P450 content in mosquitoes, it was not 
possible to determine P450 content by the traditional CO-reduced spectral assay 
(Omura and Sato, 1964b), thus protein concentrations were adjusted to 2 mg/ml to 
normalise for protein content. After 1 hr labelling incubation samples were treated with 
Rhodamine-biotin trifunctional azide for click chemistry labelling. Although strong 
labelling of a P450 sized band was observed in both strains, it was not NADPH 
dependent regardless of gel scan intensity (Figure 5.8C). A similar observation was 
seen when using Alexa Fluor® 488 azide. However, when the microsomes were 
labelled with a trifrmctional biotin reporter and affinity purified on streptavaidin 
agarose beads, NADPH dependent labelling was clearly observed in the region of 48- 
55KDa after gel fluorescence scanning. Interestingly, labelling was stronger in 
pyrethroid tolerant Tororo strain (Figure 5.9C, bottom gel). This may indicate higher 
pyrethroid metabolising activity in the pyrethroid resistance strain, possibly due to 
higher levels of CYP6P3, CYP6M2 or other P450s, although this still needs to be 
tested. Attempts were made to identify the labelled bands by mass spectrometry. 
However, this was unsuccessful due to low quantities of protein. Therefore, rat liver 
microsomes, which contain high levels of P450, were used to identify proteins reacting 
with ABPPs (see Section 5.2.6.).
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(A) PI P2 P3R P7RS PS RS
■it_________ < t NADPHi»» ^ ■ ■HI
(C)
Tororo Kisumu 
♦ - 1 ~ NADPH
I I I I 1 Pre-affinity purification
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Figure 5.8. In vitro labelling of P450s from different species with Pyrethroid 
ABPP probes. (A) Treatment of mice liver microsomal proteome (0.2 pM P450s 
content) with the suite of ABPP probes (20 pM) in the presence or absence of NADPH 
(1 mM) shows variable probes labelling specificity and strongest labelling events are 
shown with halogenated probes (P7RS and P8RS). (B) Treatment of rat liver 
microsomes proteome at 2 mg/ml protein by 20 pM of probes 2 and 7 in presence and 
absence of (1 mM) NADPH represented NADPH dependent labelling of proteins 
around 50KDa. Full SDS-PAGE separation of labelled proteins was carried out using 
4-12% Tris-Glycine gel. Labelled protein are identified by gel fluorescence scanning 
after appending AlexaFluor488-azide at 25 pM to labelled proteome via click 
chemistry (CC) reaction. (C) Treatment of microsomes proteomes extracted from 
pyrethroid tolerant (Tororo) and susceptible (Kisumu) strains of Anopheles gambiae 
mosquitoes (2-3 day old adult females) by 20 pM P7RS represented variable P450s 
levels after affinity purification. Labelled proteins were enriched on streptavidin 
agarose beads after appending Rhodamine-Biotin Trifunctional azide via CC reaction. 
Full SDS-PAGE separation was performed, but only the 48-55 kDa region is shown, 
where NADPH-dependent probe-labelled proteins were detected (consistent with the 
molecular masses of P450s).
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5.2.6. The effect of cytochrome P450 reductase and cytochrome b5 on pyrethroid 
ABPPs reactivity with P450s
For catalysis P450s require electrons from Cytochrome P450 reductase (CPR) and 
sometimes b5 (Paine et ah, 2005). In order to show conclusively that the ABPPs are 
catalytically activated by P450s it was decided to test the probes against membranes 
lacking CPR or b5. Samples of mouse liver microsomes prepared from female 
transgenic lines containing liver specific gene deletions of CPR and b5 were obtained 
from Professor Roland Wolf, University of Dundee (Finn et al, 2008; Pass et al, 
2005) and treated with probes P7RS and P8RS. The level of P450s in each sample 
were normalised and treated in presence and absence of NADPH with 20 pM 
pyrethroid ABPP. The effect of the conditional deletion of P450 redox partners CPR 
and b5 on pyrethroid ABPP probe reactivity is shown in Figure 5.9A. The levels of 
CPR activity shown in Figure 5.10B confirm the lack of CPR activity in the CPR 
knockout mice (-CPR/&5) versus wild type (CPR/65) and b5 knockout mice (CPR/- 
bS). There was very little labelling in CPR-null female mice (Figure 5.9A), consistent 
with lack of CPR activity (Figure 5.9B). This observation demonstrates that probes 
P7RS and P8RS require enzyme activation to bind and label P450s, More 
interestingly, there was reduction of P450 labelling in the b5 knockouts (CPR/-65; 
Figure 5.9A). This is consistent with the idea that b5 is not an obligate redox partner, 
but instead can enhance catalytic activity. Also it is well known that b5 often enhances 
insect P450 activity, in particular pyrethroid metabolism (Stevenson et al, 2011; 
Zhang and Scott, 1996). It was also obvious that P8RS produced a far stronger signal 
than P7RS in the absence of b5. This suggests that some of the P450s involved in 
P7RS metabolism might be less reliant on b5 for the oxidation of this pyrethroid.
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(A) CPR/b5 -CPR/b5 CPR/-b5
+ ”+ ~ ~+ ~ NADPH
CPR/b5 -CPR/b5 CPR/-b5
Mice liver microsomes samples
Figure 5.9. The effect of conditional deletion of CPR and b5 on P450s/ Pyrethroid 
CC-ABPs reactivity in mouse hepatic microsomes. (A) Liver-specific knockout of 
the essential electron transfer protein cytochrome P450 reductase (CPR), resulting in 
essentially complete ablation of hepatic microsomal P450 activity. In CPR-null female 
mouse, the treatment of liver microsomal proteome (0.2 pM P450s content adjusting 
using CO assay(Omura and Sato, 1964a)) with 20 pM pyrethroid ABPP probes in the 
presence or absence of NADPH (1 mM) did not show any NADPH-dependent probe­
labelling, where mice conditionally deleted cytochrome b5 (b5) the NADPH 
dependent probe labelling greatly influenced. [B] Typical CPR activity for mice liver 
microsomes samples used for pyrethroid ABPP treatment measured by standard 
cytochrome c reduction assay (Pritchard et al, 2006), data are average for 2 replicates.
142
5.2.7. Identification of P450s that metabolise deltamethrin using deltamethrin 
like ABPP probe (P7RS)
Probes P3R and P7RS recognise CYP6M2 and CYP6P3, enzymes that metabolise 
pyrethroids such as pennethrin and deltamethrin in An. gambiae (Muller et al, 2008; 
Stevenson et aL, 2011). To decide which probes to taken forward to determine P450 
targets in hepatic microsomes rats, initial experiments were carried out to compare 
their reactivity against rat microsomes before and after affinity purification.
Strong NADPH dependent fluorescent signals were observed in the 48-55 kDa regions 
with both probes, either before or after affinity purification (Figure 5.10). Since P7RS 
produced the strongest signal and was most similar to deltamethrin, the band was 
excised, subjected to in-gel trypsin digestion, and the resulting peptides analyzed by 
multidimensional LC-MS/MS (Wright and Cravatt, 2007) (Figure 5.11).
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Figure 5.10. Enrichment of NADPH-dependent protein targets of probe 7RS 
from rat liver proteome. Probe labelling and affinity purification was carried out 
following the methodology mentioned in material and method section (Chapter 5)
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5.2.7.X. Protein identification
Proteins were identified using the Mascot search algorithm and semi quantified by the 
exponentially modified protein abundance index (emPAI). This value offer 
approximate, label-free, relative quantitation of proteins in a mixture. This is obtained 
based on protein coverage by the peptide matches in a database search (Ishihama et al, 
2005). Based on these criteria, several specific targets that are involved in metabolism 
of drugs and pesticides were identified, all of which represented members of the P450 
super family, flavin-containing monooxygenase (FMO), aldehyde dehydrogenase, 
epoxide hydrolase and uridine S'-diphospho-glucuronosyltransferase (UDP 
glucuronosyltransferase 2B families) (Table 5.1 and Figure 5.12). Most importantly, 
P450s were the major constituent of the labelled band with (84% of total) and the most 
abundant P450 labelled was CYP2C11, a known deltamethrin metaboliser (Anand et 
al, 2006a; Anand et al^ 2006b; Godin et al., 2007; Godin et al., 2006). Furthermore, 
the second most abundant unknown gene, LOC293989, is an orthlogue of human P450 
CYP2C19 another known deltamethrin metaboliser (Godin et al, 2007) (Table 5.1 and 
Figure 5.12). Although rat P450s CYP2C6 and CYP2C11 were reported earlier to 
have higher capability to metabolise deltamethrin, with Km 21.6, 31.9 pM and Pinax 
150.0, 205.8 pmol/min/pmol P450 for CYP2C6 and CYP2C11 respectively (Godin 
et al, 2007), the CYP2C6 wasn’t identified from RLM sample. Interestingly 
sequence alignment of LOC293989 shows 97% and 74% protein sequence identity 
with deltamethrin metabolisers CYP2C6 (rat) and CYP2C19 (human) respectively 
which may suggest the involvement of this protein in pyrethroid metabolism (further 
investigation to define the function of this protein is required).
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Figure 5.11. Enrichment of NADPH-dependent protein targets of probe 7RS 
from rat liver proteome.
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Table 5.1. Enzymes labelled by P7RS in rat liver microsomes
Protein Mass Da Score8 emPAIb
1 CYP2C11 57144 1371 9.48
2 LOC293989 (orthlogues to CYP2C19) 56048 878 3.85
3 CYP2C23 56396 346 1.02
4 UDP-g2B5 precursor 49498 225 0.85
5 UDP-g 2B5 60553 231 0.74
6 CYP2C13 49660 220 0.74
7 CYP2C7 56151 336 0.72
8 CYP2D10 57039 382 0.62
9 CYP2D1 57139 339 0.62
10 CYP2D26 56648 283 0.62
11 UDP-g2B3 60485 179 0.58
12 FM03 59921 267 0.5
13 Epoxide hydrolase 52548 205 0.42
14 UDP-glucuronosyltransferase 2B4 61020 124 0.42
15 CYP2D3 56991 261 0.38
16 Aldh3a2 Fatty aldehyde dehydrogenase 54047 173 0.33
17 CYP2C13 (male-specific) 55824 144 0.31
18 CYP2B3 56348 133 0.31
19 CYP4V3 60541 163 0.29
20 CYP2C7 53254 150 0.26
21 CYP2A2 56309 104 0.24
22 CYP4F4 60011 131 0.23
23 CYP2C70 56120 164 0.18
24 CYP2A1 55959 85 0.18
25 CYP4A2 57932 107 0.17
26 CYP3A2 57694 90 0.17
(a) Ions score is -10*Log (P), where P is the probability that the observed 
match is a random event. Individual ions scores >41 indicate identity or 
extensive homology (p<0.05). Protein scores are derived from ions scores as a
non-probabilistic basis for ranking protein hits, (b) Exponentially modified 
protein abundance index.
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Although the deltamethrin metabolisers CYP2C6, CYP2C11 and CYP3A2 are known 
being expressed at high level of expression in RLM (Godin et al, 2007) however, 
CYP2C11 labbeled and identified as major protein target (46%) from RLM by P7RS 
where CYP3A2 was the lowest constituent (1%) of labbled proteins (Figure 5.12). This 
observation may confirm the sutibility of P7RS in detecting the active protein in 
deltamethrin metabolism in native proteomes. Additionally, other enzymes involved in 
pyrethroid metabolism like CYP2A1, CYP2C13, CYP2D1, and CYP3A2 (Godin et al, 
2007; Scollon et al, 2009) were identified from RLM samples (Table 5.1). These data 
shows that the deltamethrin like probe (P7RS) is capable of identifying P450,s 
associated with pyrethroid metabolism. However, other enzymes that their role in 
pyrethroid metabolism are not clearly shown have been identified in RLM sample as 
target protein which might suggest that these enzymes are linked to pyrethroid 
metabolism (warrants further investigation).
S.2.7.2. Identification of other genes pulled down by P7RS
From the results it was clear that P7RS did not just target P450s; around 16% of the 
proteins identified were other drug metabolising enzymes. These included. FMO a 
membrane binding enzyme which catalyzes the NADPH-dependent oxygenation of 
various nitrogen-, sulphur-, and phosphorous-containing xenobiotics and ALDH3a2, a 
polymorphic enzyme responsible for the oxidation of aldehyde to carboxylic acids. 
Aldehyde dehydrogenase is particularly interesting since it can operate in concert with 
P450s - following ester hydrolysis by P450s or esterases it can oxidise the 3- 
phenoxybenzaldehyde released from alpha cyano pyrethroid to 3-phenoxybenzoic 
acid.
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(A)
Enzyme super families identified P450s enzymes identified
(Phase 1 and Phase II detoxification
mechanisms)
(B)
Cytochrome P450 2C11 (Coverage: 51%, Score: 1371)
1 MDPVLVLVLT LSSLLLLSLW RQSFGRGKLP PGPTPLPIIG NTLQIYMKDI 
51 G<3SIKKFSKV YGPIFTLYLG MKPFVVLHGY EAVKEALVDL GEEFSGRGSF 
101 PVSERVNKGL GVIFSNGMQW KEIRRFSIMT LRTFCMGKRT IEDRIQEEAQ 
151 CLVEELRKSK GAPFDPTFIL GCAPCHVICS IIFQHRFDYK DPTFLNLMHR 
201 FNENFRLFSS PWLQVCKTFP AIIDYFPGSH H<JVLKHFFYI KMYVLEKVKE 
251 HQESLDKDNP RDFIDCFLNK MEQEKHNPQS EFTLESLVAT VTDMFGAGTE 
301 TTSTTLRYGL LLLLKHVDVT AKVQEEIERV IGRSRSPCMK DRSOMPYTDA 
351 VVHEIQRYID LVPTMLPHLV TRDIKFRNYF IPKGTNVIVS LSSILHDDKE 
401 FPNPEKFDPG HFLDERGHFK KSDYFMPFSA GKRICAGEAL ARTELFLFFT 
451 TILQNFNLKS LVDVKDIDTT PAISGFGHLP PFYEACFIPV QRADSLSSHL 
501
LOC293989 Cytochrome P450-likeorthologus to CYP2C19 (Coverage: 37%, Score: 878)
1 MDLVMLLVLT LTCLILLSIW RQSSGRGKLP PGPIPLPIIG NIFQLNVKNI 
51 TQSLTSFSKV YGPVFTLYFG MKPTVILHGY EAVKEALIDH GEEFAERGSF 
101 PWEKINKDL GIVFSHGNRW KEIRRFTLTT LRHLGMGKRM IEDHVQEEAR 
151 CLVEELRKTK GSPCDPTFIL GCAPCHVICS IIFQNRFDYK DQDFLNLMEK 
201 LHENMKILSS PWTQFCSFFP VLIDYCPGSH TTLAKHMYYN RNYLLKKIKE 
251 HQESLDVTNP RDFIDYYLIK WKQEHHNPNS EFTLEHLSIT VTDLFAAGTE 
301 TTSTTLRYAL LLLLKCPEVT AKVQEEIDRV VGKHRSPCMQ DRSRMPYTDA 
351 MIHEVQRFID LIPTNLPHAV TCDIKFRHYL IPKGTTIITS LSSVLHDSKE 
401 FPDPEIFDPG HFLDGNGKFK KSDYFMPFSA GKRMCAGEGL ARMELFLFLT 
451 TILQNFKLKS VLHPKDIDTT PVFHGFASLP PFYELCFIPL
Figure 5.12. Proteins identified in rat liver microsomes after incubation with the 
deltamethrin like probe P7RS in the presence of NADPH. (A) Percentage 
constitution of Phase I and phase II detoxification enzymes activities labelled by P7RS 
in rat liver microsomes, calculated based on emPAI for each identified Enzyme 
(Ishihama et al, 2005), relative protein abundant calculated by dividing emPAI value 
of the protein by the total emPAI total protein time 100 B) Top two P450s enzymes 
identified, matched peptides shown in Bold Red, Tryptic Peptides Identified by LC- 
MS/MS Analysis for P7RS-Enriched P450 Enzymes from rat liver proteomes.
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This may also support the idea that release of the reactive species can produce labelling 
to proteins in vicinity of active P450s. Interestingly, the most abundant phase II 
(conjugative) detoxification protein was UDP-glucuronosyltransferase (11% of protein 
identified (Figure 5.12). These enzymes catalyze the addition of the glucuronic acid 
moiety to xenobiotics for elimination from the body (King et aL, 2000), including 
glucuronic conjugation of permethrin ester hydrolysis products in rats (Figure 5.13) 
(Noort et al, 2008). It is therefore feasible that such compounds could form protein- 
pyrethroid conjugates upon transacylation mechanism or via Amadori product 
formation (Noort et al, 2008) (Figure 5.14).
5.3. Conclusions
A set of type I and type II pyrethroid mimic probes , P2, 3R, 4S, 5R 6S, 7RS and 8RS 
have been developed. In general, the pyrethroid ABPP probes lacking bromine atoms 
displayed lower probe labelling activity relative to P7RS and P8RS the halogenated 
deltamethrin-like ABPP, indicating that the halogen atoms may be important in P450 
active site recognition. The ABPPS may also help in understanding the function of 
redox partners such as CPR and b5 on regulating activity of P450s that metabolise 
pyrethroid. For instance, the liver-specific knockout of CPR which knocked out P7RS 
and P8RS labelling in mouse microsomes (Figure 5.9) confirmed the MBI mechanism, 
while the reduction in labelling intensity in b5 knockout mice indicates a cooperative 
role in enhancing activity. Finally, the present study has exploited the ability of 
pyrethroid ABPPs to label P450 sized molecules in rodent and mosquito microsomes. 
The deltamethrin ABPP P7RS was the most potent probe and used for this study 
because of its potency and common use of deltamethrin in vector control.
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Affinity purification and enrichment of non induced rat liver P450s, showed that 
labelled proteins mainly belonged to phase I and II detoxification enzyme super 
families. 85% of the labelled were P450s, and the major two abundant enzymes 
detected were CYP2C11 and the orthlogues to CYP2C19 in human; both are 
confirmed deltamethrin metabolisers (Anand et al, 2006a; Anand et aL, 2006b; Godin 
et al, 2007; Godin et al, 2006). Thus P7RS targets several key members of P450 
subfamilies that contribute to pyrethroid metabolism ie., CYP2C11, CYP3A2.
In summary, a novel set of selective pyrethroid ABPPs have been developed that 
satisfies the major criteria expected for identification of enzymes associated with 
pyrethroid metabolism including; (i) NADPH dependent labelling of catalytic P450 
enzymes, and (ii), targeting and labelling of several CYP enzymes associated with 
pyrethroid resistance with minimal cross reactivity with other proteins.
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Figure 5.14. Postulated metabolism of probe 7RS in RLM that leads to UDP- 
glucuronosyltransferase adducts. (A) metabolism of P7RS in mammals. (B) Adduct 
formation of acylglucuroindes with proteins by means of the Amadori rearrangement, 
dashed arrows refer to free acetylene for click reaction.
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5.4.Materials and methods
5.4.1. Chemicals and reagents
The pyrethroid ABPPs used are shown in Figure 5.15, Probe 1 (PI) a general P450 
probe and the rhodamine biotin trifimctional azide were kindly provided by Cravatt’s 
laboratory, Scripps Research Institute, USA. Biotin azide was kindly given by 
Professor Paul O' M Neill, Liverpool University. b-Nicotinamide adenine 
dinucleotide phosphate, reduced form, tetrasodium salt (NADPH) were obtained from 
Melford, UK.
Luminescent P450 activity assays were performed in white 96-well plates (Thermo 
Fisher Scientifc, Hudson, NH) using the commercially available P450-Glo’s substrate 
Luciferin-PPXE (Promega, Madison, WI). DMSO solvents were reagent grade Sigma 
Aldrich. The click chemistry ligand, tris [(1-benzyl-1H-1,2,3-triazol-4- 
yl)methyl]amine, was purchased from Sigma-Aldrich Chemical Co. (UK). Alexa 
Fluor® 488 azide was purchased from Invitrogen Company (UK).
5.4.2, Microsomes preparation
Rat liver microsomes: Rat liver microsomes prepared from male Wistar rats which 
had P450 contents 0.52 nmol/mg proteins measured by CO assay (Omura and Sato, 
1964a) was kindly provided by Dr. Alison Shone, Molecular Biochemical Parasitology 
group, Liverpool School of Tropical Medicine, Liverpool, UK.
Mouse microsomes: Male mouse liver microsomes samples prepared from transgenic 
animals that have conditional deletions of liver CPR or b5 along with normal mouse 
controls were kindly provided by Professor Roland Wolf, Biomedical Research 
Institute, University of Dundee (UK).
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N=N=N—(CH2)6NH“C
Alexa Fluor 488 Azide Rhodamine-Biotin Trifunctional Azide
Figure 5.15. Chemical structures of pyrethroid ABPPs and Azide reporters. (A)
Pyrethroid ABPPs shown were generated by including a reactive warhead (red 
acetylene) at a predicted primary site of oxidation, and a latent click handle (blue 
acetylene group) either in the middle replacing the alpha cyano group or at terminal 
position replacing bromine atoms. PI is 2EN-ABPP, a generic positive control probe. 
R and S refer to pyrethroid enantiomer. (B) Copper based click reaction azide reporter 
used in detection and ABPP target pull-down.
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Mosquito microsmes: Mosquito microsomes were prepared as described by Inceoglu 
et al. (Inceoglu et al, 2009) with some modifications. Briefly: preparation of 
mosquitoes microsomes from adults (~200 individuals per colony) were done by 
removal of the heads to avoid enzyme inhibition from xanthommatin eye pigments 
(Schonbrod and Terriere, 1971).
Mosquitoes were treated with liquid nitrogen in a sieve ~2 min mesh size. Small steel 
balls were gently shaken over the mosquitoes to fractionate their bodies and to separate 
the smaller heads, legs, wings parts from the joint abdominal-thoracic components. 
The thoracic abdominal complex was then washed with 3 ml of ice-cold 
homogenization buffer (HB: 0.1 M sodium phosphate (Sigma), pH 7.5, 1 mM 
phenylmethylsulphonyl fluoride (PMSF, sigma), 0.1 mM dithiothreitol (DTT, 
Invitrogen), and 1 mM l-phenyl-2-thiourea (PTU, Sigma). The PMSF and PTU were 
dissolved in ethanol and added to the HB such that concentration of ethanol never 
exceeded 1% (vokvol) of the total buffer volume, filtered and re-suspended in 10 ml of 
HB, The microsomes were prepared by homogenization of the complex by 40-ml glass 
Bounce homogenizer with a loose B pestle (Wheaton Science, Millville, NJ). The 
separation of the homogenate into cytosolic and microsomal extracts was done with 
centrifugation steps at 4° C. The initial centrifugation was performed at 10,000 xg for 
15 min to remove insoluble debris. A second centrifugation at 100,000 xg for 1 h was 
performed to pellet the microsomes. The microsomal pellet was resuspended in 500 pi 
of ice-cold resuspension buffer (HB without PTU but contains 20% glycerol). Protein 
concentration was measured in triplicate by the Bradford method (Bradford, 1976) 
with Bio-Rad reagents using bovine serum albumin as a protein standard.
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5.4.3. Western blot detection
Stock solutions were made of ABPP probes (PI, P2, P3R, P4S, P5R, P6S, P7RS 
and P8RS) in DMSO (20 mM), CuS04 in water (50 mM), Tris(2- 
carboxyethyl)phosphine hydrochloride (TCEP) in water (50 mM), and Tris-triazolyl 
ligand (TBTA) (1.7mM in 4:1 r-butanol: DMSO). Recombinant CYP6P3 normalised 
to 0.2 pM in Dulbecco Phosphate Buffer Saline pH 7.4 (D-PBS obtained from 
Invitrogen) and treated with pyrethroid ABPP probe 2 at 10 pM in presence and 
absence of 1 mM NADPH (Sigma). Samples were incubated at 37°C for 1 hr, and, 44 
pi of sample transferred to a clean eppendorf tube for tag (biotin azide reporter) 
treatment.
In accordance with click chemistry (CC) conditions optimized by Speers and Cravatt 
(Speers and Cravatt, 2004b) samples were treated with Ipl of biotin-azide (2.5 mM 
stock in DMSO) followed by 1 pi of freshly prepared TCEP (50mM stock in water) 
and 3.3pi of ligand (1.7 mM stock in DMSO:t-butanol 1:4) giving a t-butanol 
concentration of 5%. Samples were gently vortexed and Ipl of CuS04 (50mM stock in 
water) were added. Each sample was gently vortexed and allowed to react at room 
temperature for 1 hr in the dark with regular vortexing every 15 min. The reaction was 
quenched by addition of 200 pi of cold methanol. Then samples were briefly 
centrifuged (5900g, 4 min at 4°C) to pellet the precipitated protein and remove excess 
reagents. The supernatant was discarded and 50 pi (1 volume) of D-PBS and 50 pi (1 
volume) of standard 2x SDS-PAGE loading buffer (reducing) were added to the 
protein pellet. Samples were sonicated to solubilise the proteins and heated for 8 min at 
90° C. Proteins were then separated by SDS-PAGE (~30 pg of protein/gel lane) and
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transferred by electro blotting (semi dried) onto nitrocellulose membranes. Membrane 
was blocked in phosphate buffer saline (TPBS) with 1% Tween and 3% (wt per vol) 
bovine serum albumin (Sigma) fraction V, either 1 h at 25°C or overnight at 4°C. The 
blot was washed three times with washing buffer (0.1% TPBS). Then the blot was 
treated with an avidin-horseradish peroxidase conjugate (1:10000 dilutions) in TPBS 
with 1% BSA for 1 hr at 25°C. Thereafter the blot was washed with TPBS three times 
(10 min wash), treated with SuperSignal West Pico chemiluminescent substrate 
(Pierce, UK), and exposed to film for 0.1 to 15 min before development. The relative 
amounts of pyrethroid probe-biotin labelling were estimated by film densitometry.
5.4.4. Labelling of P450 enzymes by pyrethroid ABPP probes
Recombinant P450 proteomes CYP6P3, CYP6M2 and CYP6Z2 were normalised 
to 0.2 pM in D-PBS pH 7.4 and treated with ABPPs at 20 pM in the presence and 
absence of 1 mM NADPH. Samples were incubated at 37°C for 1 hr. Thereafter, 44 pi 
of sample was transferred to a clean eppendorf tube for reporter addition (Alexa 
Fluor® 488 azide reporter 0.5 pi of a 5 mM stock solution in DMSO). Following 
addition of reporter the click chemistry (CC) reaction was proceeded with conditions 
optimized by Speers and Cravatt(Speers and Cravatt, 2004b) mentioned above. 
Following the addition of CC reagents samples were vortexed and left at room 
temperature in the dark for 1 hr, at which time 2x SDS-PAGE loading buffer 
(reducing) was added to each reaction. The samples were heated at 90° C for 8 min and 
then 30 pi per well loaded onto gels NuPAGE® Novex 4-12% Bis-Tris Gel 
(Invitrogen, UK). After electrophoresis, gels were rinsed in a destain solution (5:4:1
water/methanol/acetic acid) overnight (in the dark), and fluorescence intensities were
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measured by using Ettan DIGE Laser imager (GE Healthcare) at CY2 filter. Equal 
protein loading was confirmed by using Gel code Blue® Coomassie stain (Pierce, 
UK).
5.4.5. Identification of deltamethrin like ABPP targets in rat liver microsomes.
Liver microsomal proteome samples (1 ml of 2 mg/ml protein in PBS) were treated
with either probe 3 or 7RS (10 GM, 2.0 GL of a stock solution in DMSO) in the
presence or absence of 1 mM NADPH. The samples were incubated at 37° C for 45
min and then treated with a trifunctional azido biotin-rhodamine reporter group (4.0 pi
of a 5 mM stock solution in DMSO) followed by vortexing. Click reaction was
preceded by addition of CC’s regents as mentioned in previous sections and left at
room temperature in the dark for 1 h. Following the click reaction incubation probe
labelled proteins was enriched according to Wright and Cravatt (Wright and Cravatt,
2007) using streptavidin agarose beads. Briefly, samples were centrifuged (5,900 xg, 4
min, 4° C) to pellet the protein. The supernatant was discarded and cold methanol (0.40
ml) was added to the pellets and the proteins were resuspended by sonication (3-5 s)
and then rotated (10 min, 4°C). The centrifugation step was repeated, the supernatant
discarded, and methanol (0.40 ml) was added to the pellets and the proteins were
resuspended by sonication (3-5 s) and then rotated (10 min, 4° C) once again. The
samples were pelleted by centrifugation once more, and the supernatant discarded.
PBS (1.0 ml) containing SDS (1,2%) was added to the pellets and subsequently
resuspended by sonication (3-5 sec). The samples were heated at 90° C for 8 min and
then cooled to room temperature. Proteins were then enriched by rotating samples (1.5
h) with streptavidin-agarose beads (0.1 ml suspension solution) in a PBS media diluted
to 0.2% SDS. The PBS media was removed and the beads were rinsed with 0.2% SDS
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in PBS (1.5 ml, 3x), urea (6.0 M, 1.5 ml, 3x), and PBS buffer (1.5 ml, 3x). SDS-PAGE 
loading buffer (2x, reducing, 50(il) was added to the beads and heated at 90° C for 8 
min. The samples (35 pi) were loaded onto SDS-PAGE gels and separated. Gels were 
imaged onto Ettan DIGE Laser imager (GE Healthcare) at CY3 filter to determine the 
labelling in presence and absence of NADPH. Following imaging, the gel coomassie 
stained using Gel code Blue® Coomassie stain (Pierce, UK). The darkly stained bands 
from 48-55 kDa were excised with a razorblade and diced into small cubes.
The gel pieces were washed with water and sent to finger prints proteomic facilities 
lab, Dundee University, UK (http://proteomics.lifesci.dundee.ac.uk/rates.html) for 
trypsin digestion and nLC-MS/MS analysis.
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Chapter 6
6. Final discussion
Novel tools and research methods that enable the direct and selective identification of 
the P450s active in insecticide metabolism and therefore linked to resistance at a 
mechanistic level was the major objectives of this PhD project. To achieve this goal we 
designed and synthesised pyrethroid mimetic ABPP probes following rational design 
approach. This approach recently, proved enormous befit towards designing selective 
and potent inhibitor for Fatty acid amide hydrolase (FAAH) in which can be directed 
to develop ABPP for FAAH (Ahn et al, 2009; Alexander and Cravatt, 2005).
6.1.Investigating mechanism-based inhibition of P450s by selected arylalkynes
Certain arylalkynes, i.e. lEPh, 4EBi, 2EMe, 2POX and 4EDF, were selected for their 
structure similarity with alcohol moieties in deltamethrin, bifenthrin and other 
pyrethroid recommended for ITNs treatment by WHOPES (Figure 1.4, Chapter 1). 
Their ability to act as MBI was used as an indication of their ABPP capacity. While the 
rigid biphenyl structure like 4-EBi proved a MBI for RLM (Foroozesh et al, 1997), 
flexible arylalkyne like lEPh has not been examined before for MBI against P450. The 
most important observation is that flexible structures, i.e. lEPh, 2POX and 2EMe, 
showed significant MBI for RLM and NADPH dependent inhibition for CYP6P3. This 
result draws attention to the size and shape of the molecule being important parameters 
for inactivation of pyrethroid metaboliser CYP6P3. lEPh in particular* proved 
interesting because this contains a phenoxybenzene moiety commonly found in 
pyrethroid and ethynyl group substituted at the primary site of oxidation by P450s 
(para position) (Stevenson et al, 2011).
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6.2.Rational design of pyrethroid ABPPs
The rigidity of arylalkyne seemed to play an important role in directing the molecule in 
CYP6P3 active site for oxidation leading to MBI for P450. Therefore, to further 
confirm this hypothesis and get an insight into the MBI of pyrethroid molecules 
bearing an arylalkyne moiety, the MBI inhibition of CYP6P3 was examined using 
composite deltamethrin and bifenthrin analogues containing 2POX and 4-EBi (Chapter 
3). In general deltamethrin and bifenthrin analogues containing 2POX further 
confirmed NADPH dependent inhibition for CYP6P3 including C3 and C4, against 
those with a rigid arylalkyne moiety (4EBi) that did not. However, spectroscopic 
analysis and HPLC metabolism profiles of C3 and C4 showed these compounds to be 
substrates (rapidly degraded in many metabolites) for CYP6P3 (Figure 3.2 and Fig.3.3 
Chapter 3). This paradoxical observation can be explained if NADPH dependent 
mhrbition was due to irreversible binding of metabolites rather than the parent 
compounds. This is further supported by the fact that P450s can attack multiple sites 
on the same substrate and therefore produce multiple metabolites (Stevenson et al, 
2011). The metabolites observed by HPLC warrants further investigation, although the 
complexity of CYP6P3 inactivation diminishes the opportunity for further using C3 
and C4 compounds as templates for activity based protein profiling probes design.
6.3.In silico prediction of pyrethroid inhibitors binding to CYP6P3
In silico modelling study has provide a useful approach in predicting drug-P450 
interaction (McLaughlin et al, 2005). A homology model of CYP2D6, together with 
molecular docking techniques has been utilised earlier to perform in silico screen for 
inhibitor binding to CYP2D6 and to inform the possible sites of drug metabolism by
P450 (McLaughlin et al, 2005; Yu et al, 2006). Here, the available CYP6P3
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homology model (Stevenson et al, 2011) was also used to help predict the key 
pyrethroid—active site interactions, and indicates on how the molecule might be 
oriented in the CYP6P3 active site allowing enzyme inactivation and labelling.
Initially, inhibitor docking calculations suggested that the length of the alcohol group 
in both C3 and C4 is likely to influence binding posture in a more favourable position 
for the metabolism at ester bond. This representation suggest that using phenoxybenzyl 
moiety based aryl alkyne such as (lEPh) to design the pyrethroid ABPP may be the 
most favourable choice to help enhance the probe binding in modes that would allow 
for metabolism at the alcohol side of the molecule. Therefore, a number of novel 
pyrethroid ABPP probes were designed based on the lEPh analogues or propargyl 
ether (2POX) (Figure 3.5).
These compounds were based on the chemical scaffold of deltamethrin, with 
modifications on the terminal bromine atom end or the middle alpha cyano group to 
provide an acetylene group for the click handle. Docking calculations with the 
CYP6P3 structural model predicted that those probes containing a phenoxybenzyl 
moiety were most likely to have high affinity binding in a relevant orientation for 
oxidation leading to irreversible inhibition. Pyrethroid ABPPs that contain bromine 
atoms were predicted to have higher binding affinity comparable to non halogenated 
probes. All compounds designed based on phenoxybenzyl moiety were taken forward 
and synthesised as illustrated and discussed in chapter 4.
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6.4.Pyrethroid ABPP probes validation
6.4.1. Identification of P450s metabolise deltamethrin using deltamethrin like 
ABPP probe (P7RS)
Comparative profiling study of the synthesised pyrethroid ABPP probes was carried 
out against An. gambiae recombinant P450s in association with pyrethroid resistance 
including CYP6P3, CYP6M2 and CYP6Z2, We pursued this study to confirm that 
P450s were legitimate targets of the novel pyrethroid ABPPs, and to identify probes 
that selectively label P450 pyrethroid metabolisers in an activity-based manner. The 
probe library was reactive against P450s and demonstrated mechanistic labelling of 
recombinant P450s, albeit with variable selectivity and specificity (Figure 5.5). 
Cytochrome P450s involved in pyrethroid metabolism, CYP6M2 and CYP6P3, were 
broadly labelled by the pyrethroid ABPPs, whereas the non pyrethroid metaboliser 
CYP6Z2 displayed more limited labelling. However, all pyrethraid ABPPs that lacked 
bromine atoms (P3R, P4S, P5R and P6S) displayed lower or minimal probe labelling 
in comparison with bromine containing P7RS and P8RS. This suggests the importance 
of the halogen molecules in P450 active site recognition, consistent with modelling 
predictions (Chapter 3). Furthermore, probes P3R and P7RS which contains acetylene 
group at para position of phenoxybenzyl moiety (4' position) appeared to favour the 
labelling of the pyrethroid metabolisers CYP6P3 and CYP6M2. This is consistent with 
para hydroxylation being the major site of metabolism by these P450s (Stevenson et 
al-> 2011), validating the positioning of the acetylene ‘warhead’. The deltamethrin like 
probe P7RS in particular showed selective and strong labelling of CYP6P3 and 
CYP6M2 consistent with their role in pyrethmid metabolism (Muller et al, 2008; 
Stevenson et al, 2011).
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6.4.2. In vitro labelling of P450s from different species
When tested against rodent and mosquito microsomes, pyrethroid ABPPs 
demonstrated a broad range of potential applications in the functional characterisation 
of P450 activities from different biological samples i.e. they labelled P450 sized bands 
across species.
Cytochrome P450 enzymes requires the transfer of two electrons from cytochrome 
P450 reductase (Farooq and Roberts, 2010; Meunier et al., 2004; Omura and Sato, 
1964b; Paine et al, 2005). These electrons are donated by NADPH; therefore, the 
catalytic activity of P450s is NADPH and CPR dependent. Thus conditional deletion 
of CPR in mouse was used as an additional control to further confirm the mechanistic 
labelling of P450 by P7RS and P8RS. Liver-specific knockout of the essential electron 
transfer protein (CPR) resulting in essentially complete abolition of hepatic 
microsomal P450 activity consistent with CPR’s role in P450s activity was 
successfully measured upon using probes P7RS and P8RS. In addition, mouse liver 
microsomes that has conditional deletion of b5 was greatly affected labelling intensity 
obtained with either P7RS or P8RS..
6.4.3. Pyrethroid ABPP labeling of rat liver microsomes
An affinity purification and enrichment of non induced rat liver P450 using probe
P7RS, further proved the mechanistic labelling of P7RS for P450s where only
NADPH dependent band presented either before or after affinity purification.
Additionally, the LC-MS/MS analysis for trypsin digested NADPH dependent band
were identified many P450s proteins. However P7RS also shows the capability to label
enzymes belonged to phase I and phase II detoxification enzyme super families. The
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P450s constituted about 85% of the enzymes identified, while the major two abundant 
enzymes detected were CYP2C11 and an orthlogues of human CYP2C19. The 
CYP2C11 and CYP2C19 are both known to mediate pyrethroid metabolism and then- 
role in metabolism of deltamethrin are well characterised and confirmed (Godin et al, 
2007; Godin et al., 2006). Thus the major objective of the thesis has been achieved. It 
is also apparent that P7RS targets many P450s whose role in pyrethroid metabolism is 
not established, and it will be interesting in future to examine these further. More 
interesting perhaps was the fact that P7RS did not target only P450s. 16% of the 
proteins identified included flavin-containing monooxygenases (FMO), ALDH3a2, 
epoxide hydrolase and UDP-glucuronosyltransferase, which are also associated with 
detoxification. Of these, the most important enzyme in Phase II (conjugative) 
detoxification mechanism was UDP-glucuronosyltransferase, which represented 11% 
of the protein identified in this sample (Figure 5.14). These enzymes are known to 
catalyze the addition of the glucuronic acid moiety to xenobiotics which turn the 
molecule in hydrophilic form easy to be eliminated from body (King et al, 2000). In 
summary the utilisation of probe P7RS has addressed three important points: first, 
P7RS has selectively identified directly P450s important in deltamethrin metabolism 
like CYP2C11. Second, this probe targets and identifies proteins with unknown 
function such LOC293989 where bioinformatics shows great structural similarity with 
pyrethroid metaboliser CYP2C6 (rat) and CYP2C19 (humane). Third, P7RS 
successfully identified proteins from other super family that involved in pyrethroid 
metabolism such as FM03, Aldehyde dehydrogenase and UDP- 
glucuronosyltransferase.
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6.5.Conclusion and perspectives
We developed a suite of novel pyrethroid ABPP that shows effectiveness in detection 
and identification of CYP enzymes functional activity in pyrethroid binding and 
metabolism either in recombinant or in native proteomic samples. These probes not 
only proved the capability for addressing the functional state of CYP enzymes but also 
proved its capability to selectively label and identify the essential enzymes in 
pyrethroid metabolism in hepatic microsomes from rat.
Due to low level of P450 content in mosquito’s samples, gel based protein
identification failed to identifyP450 bound probes purified from these samples
although significant NADPH dependent labelling was observed after affinity
purification (Figure 5.8, Chapter 5). New LC-MS/MS with high resolution in tandem
with recently developed MudPIT-CC-ABPP (Jessani et al, 2005; Speers and Cravatt,
2009) may provide a significant approach for future work to identify and quantify
functional enzyme activity in samples such as mosquitoes with low P450s content.
This method is not only quite desirable for identification of low content enzymes but
also could be consolidated in single experiment to identify probe-site labelling which
extend the application of pyrethroid ABPP beyond identifying essential enzymes to
identify the catalytic residue in the active site. Identification of probe site labelling can
be consolidated with genetics tools to map active site which may provide useful data to
enhance the computational approaches like in silico models. For example identification
of probe-site labelling could greatly help in identifying important single nucleotide
polymorphism (SNP) changes that alters P450 enzyme activity in pyrethroid resistant
strains. In other words, pyrethroid ABPP can be linked to computational modelling and
site directed mutagenesis to map the P450 active site in order to detennine the amino
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acid residues have detrimental effect on substrate active site recognition and labelling. 
For example the comparative profiling study with probe 2 (Figure 5.3, chapter 5) has 
clearly confirmed the probe selectivity to bind CYP6P3. Therefore, this probe was 
taken forward in a pilot study in combination with molecular modelling, to 
systematically map the active site of CYP6 enzymes and to identify the residues 
involved in molecular recognition of the probe. The structure modelling was used to 
predict the binding mode of the probe that leads to irreversible binding and to predict 
the residues that discriminate probe labelling between the CYP6P3 and CYP6M2 
enzyme. The predicted binding modes of probe 2 in CYP6P3 and CYP6M2 active site, 
represented steric differences between the active sites that may determine binding 
leads to effective metabolism (Figure 6.1). In CYP6M2 the Vafe projects into the 
active site in a position to cause clashes with the substrate, supported by two flanked 
proline residue Proayi and Proa73 in substrate recognition site 5 (SRS5 backbone). Also, 
the model predicts the nucleophilic residue Tlii’ais in CYP6P3 as the possible target 
residue to react with the reactive species (ketene intermediate) to form a covalent 
adduct (Figure 6.1 and Scheme 6.1). Therefore the consideration was given to mutate 
and replace this residue with inactive threonine analogue ‘alanine residue’ using site 
directed mutagenesis to check its function in enzyme catalytic activity and probe 
labelling. Although the data obtained from gene sequencing of the mutant plasmid has 
been confirmed successful mutation but the functional expression of the mutant 
CYP6P3 was not successful. However, the bioinformatics study pointed out that this 
residue is quite conserved through panel of CYP enzymes including CYP3A4, 
CYP6M2, CYP6Z2 and CYP6P3, which may justify the importance of Thi’318 in P450 
structure stability.
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Figure 6.1. Selective labelling of 6P3 by type I pyrethroid mimic probe P2. (A)
Labelling of 6P3 and 6M2 by pyrethroid ABPP (P2) (B) Molecular modelling showing 
the binding of P2 (violate stick) in the active site of CYP6P3 and CYP6M2. Probe 2 
was docked into the active site of CYP6P3 and CYP6M2 using GOLD docking 
software as mentioned in material and method section (chapter 3). I-helix and the heme 
are shown in green ribbon and red stick for CYP6P3 and CYP6M2, respectively. 
Amino acid residue proposed to be targeted by ketene generated from oxidation of P2 
leads to covalent adduct is shown in CYP6P3 and CYP6M2 models. Steric differences 
ot the active site between CYP6M2 and CYP6P3 are illustrated by showing the 
binding site domain SRS5 of booth enzymes. In 6M2 the V372 projects into the active 
site in a position to cause clashes with the substrate, supported by to flanked prolines 
residue.
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Scheme 6.1. Proposed mechanism for the formation of P2-protein adducts.
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Further characterisation of other amino acid residues is being investigated to map the 
active site for amino acids essential in probe recognition and labelling. However, we 
believe that probe-site labelling identification using mass spectrometer will have a 
direct answer in such direction and provide more information for enhancing in silico 
modelling studies. In general the ABPP approach is quite amenable for being applied 
in different platforms and we envisage that this will encourage the wide use of 
pyrethroid ABPP in several research themes from structural and functional analysis to 
developing highly miniaturized protein microarray for measuring P450s activities in 
pyrethroid resistant and susceptible strains.
For example, since pyrethroid ABPPs are quite close to the structure of synthetic 
pyrethroids, utilising this approach in competitive inhibition screening of new 
compounds could afford high throughput tools for screening new synergists, and 
insecticides at molecular’ as well as cellular' levels. This eventually will help in 
accelerating the development of selective and exceptionally active insecticides. 
Furthermore, the availability of high quality antibodies against a panel of mosquitoes 
P450s essential in pyrethroid metabolism could be devised to develop ABPP- 
microarray. Protein microarrays provide a novel approach of miniaturized platform of 
ABPP that can consolidate into single step the isolation, detection, and identification of 
probe labelled enzymes (Figure 1.15 Chapter 1) (Sieber et al., 2004). This system is 
expected to exhibit higher sensitivity and resolution than gel technology, sufficient to 
differentiate CYP enzymes activities between pyrethroid susceptible and resistant 
insects. In summary, P450-directed ABPs probes will have the potential to serve as
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valuable research tools for the functional characterization of this large and diverse 
enzyme family and help in providing addressing answers to different controversial 
research themes like protein/protein interaction.
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Appendix I
Cytochrome P450 destruction assay
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tea__ 470 480 4>0 500
-0.02
-0.03
-0.04
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Control-NAOPM ControkNADPH 0_mln 30_min
Figure A.1.1. Carbon monoxide spectroscopic analysis (CO Spec) of Rat Liver 
Microsomes (0.4 uM) before and after incubation at 37°C with 10 uM of 2-ethynyl-6- 
methoxynaphthalene (2EMe) in presence and absence of NADPH. P450 content was 
measured by addition of reducing agent NaiSzO.* (~1 mg) to each cuvette and a 
reference spectrum from 400 to 500 nm recorded. CO was gently bubbled into the 
solution in the cuvette for 1 min, the cuvette was immediately capped, and the 
spectrum between 400 and 500 nm was measured.
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Figure A.I.2 Carbon monoxide spectroscopic analysis (CO Spec) of Rat Liver 
Microsomes (0.4 uM) before and after incubation at 37°C with 10 uM of l-ethynyl-4- 
phenoxybenzene (lEPh) in presence and absence of NADPH, P450 content was 
measured by addition of reducing agent Na2S204 (~1 mg) to each cuvette and a 
reference spectrum from 400 to 500 nm recorded. CO was gently bubbled into the 
solution in the cuvette for 1 min, the cuvette was immediately capped, and the 
spectrum between 400 and 500 nm was measured.
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Figure A.I.3. Carbon monoxide spectroscopic analysis (CO Spec) of Rat Liver 
Microsomes (0.4 uM) before and after incubation at 37°C with 10 uM of 4-ethynyl-l, 
2-difluorobenzene (4EDF) in presence and absence of NADPH, P450 content was 
measured by addition of reducing agent Na2S204 (~1 mg) to each cuvette and a 
reference spectrum from 400 to 500 nm recorded. CO was gently bubbled into the 
solution in the cuvette for 1 min, the cuvette was immediately capped, and the 
spectrum between 400 and 500 nm was measured.
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Figure A.I.4. Carbon monoxide spectroscopic analysis (CO Spec) of Rat Liver 
Microsomes (0.4 uM) before and after incubation at 37°C with 10 uM of 4-ethynyl-l, 
1’-biphenyl (4EBi) in presence and absence of NADPH, P450 content was measured 
by addition of reducing agent ^28264 (~1 mg) to each cuvette and a reference 
spectrum from 400 to 500 nm recorded. CO was gently bubbled into the solution in the 
cuvette for 1 min, the cuvette was immediately capped, and the spectrum between 400 
and 500 nm was measured.
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Appendix II
1 13HNMR and C spectrum of synthesised pyrethroid ABPP probes
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